The Regulation of Prokaryotic Transposable Elements by the RNA Binding Protein Hfq by Munshaw, Brian J
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
11-12-2012 12:00 AM 
The Regulation of Prokaryotic Transposable Elements by the RNA 
Binding Protein Hfq 
Brian J. Munshaw 
The University of Western Ontario 
Supervisor 
Dr. David Haniford 
The University of Western Ontario 
Graduate Program in Biochemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Brian J. Munshaw 2012 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Biochemistry Commons 
Recommended Citation 
Munshaw, Brian J., "The Regulation of Prokaryotic Transposable Elements by the RNA Binding Protein 
Hfq" (2012). Electronic Thesis and Dissertation Repository. 935. 
https://ir.lib.uwo.ca/etd/935 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
  
 
 
 
 
The Regulation of Prokaryotic Transposable Elements by the RNA Binding 
Protein Hfq 
 
(Spine title: Hfq and Transposable Elements) 
 
(Thesis format: Monograph) 
 
by 
 
Brian Munshaw 
 
Graduate Program in Biochemistry 
 
A thesis submitted in partial fulfillment 
of the requirements for the degree of 
Master of Science 
 
The School of Graduate and Postdoctoral Studies 
The University of Western Ontario 
London, Ontario, Canada 
 
 
© Brian Munshaw 2012 
 
  
 i 
THE UNIVERSITY OF WESTERN ONTARIO 
SCHOOL OF GRADUATE AND POSTDOCTORAL STUDIES 
 
 
CERTIFICATE OF EXAMINATION 
 
 
Supervisor 
 
______________________________  
Dr.  David Haniford  
 
 
Supervisory Committee 
 
______________________________  
Dr.  Christopher Brandl 
 
______________________________  
Dr.  David Edgel 
Examiners 
 
______________________________  
Dr. Christopher Brandl 
 
______________________________  
Dr. Ze-Chun Yuan 
 
______________________________  
Dr. Stan Dunn 
 
 
 
The thesis by 
 
Brian James Munshaw 
 
entitled: 
 
 
THE REGULATION OF PROKARYOTIC TRANSPOSABLE ELEMENTS BY 
THE RNA BINDING PROTEIN HFQ  
 
is accepted in partial fulfilment of the  
requirements for the degree of  
Master of Science 
 
 
 
Date__________________________ _______________________________ 
Chair of the Thesis Examination Board 
  
 ii 
Abstract 
 This thesis investigates the role that the RNA binding protein Hfq has in 
regulating the mobility of IS Elements and the expression of their transposase 
genes.  Hfq is a known regulator of the IS Element IS10 and is a major 
component of sRNA pathways in E.coli.  In this work, I demonstrate that through 
the use of a bioinformatics approach to identify a list of additional IS Elements 
from the IS Finder database, one can successfully identify IS Elements 
containing Hfq binding sites which may implicate Hfq regulation.  One of the 
identified elements, IS1413, was characterized by transposition assays and 
transposase expression assays. These experiments demonstrated that the 
activity level of IS1413 decreases in the presence of Hfq. Another identified IS 
Element, IS10, had its 3’ end of its transposase mRNA transcript probed for the 
relevance of a putative Hfq binding site through mutational analysis, and through 
identifying that there are no post-transcriptional modifications at the 3’ end of the 
transcript. Although Hfq bound IS10 mRNA in vitro, genetic mutations to the 
putative Hfq binding site resulted in no difference in transposition activity.  A 
growth condition was identified that increased IS10 transposition frequencies in 
wild type cells, but not in cells containing a rpoS gene disruption.  Overall, these 
studies have identified another IS Element that changes activity in the presence 
of Hfq and have linked slow unaerated growth conditions to an increase in IS10 
transposition frequencies in E.coli.  
Key words: IS10/Tn10, IS1413, Hfq, Stress Conditions, Transposition, E.coli, 
Burkholderia phenoltripix, IS Finder 
 iii 
Acknowledgements  
 I would like to thank my supervisor David Haniford.  Thank you for your 
guidance, feedback, and great conversations about science (and fishing) at lab 
coffee meetings.  I would also like to extend my thanks to my colleagues (past 
and present) Joe Ross, Crystal McLellan, Ryan Trussler, Shahan Hossain, Mike 
Ellis and Morgan Black for the support and great conversations.  I like to thank 
my graduate committee Dr. Edgell, and Dr. Brandl for their support in terms of 
motivation and research considerations.  I would also like to thank Barb Green 
and her administrative team for their help in answering questions regarding 
department policies and procedures.  A special thank you goes out to my wife 
Brie Munshaw who has supported me throughout this thesis and has offered me 
nothing but encouragement and motivation to continue this journey.  I would also 
like to thank my family and friends for all their love and support. 
 Thank you to the University of Western Ontario and the Province of 
Ontario for providing me with this valuable opportunity as well as funding to 
pursue it. 
  
 iv 
Table of Contents 
The Regulation of Prokaryotic Transposable Elements by the RNA Binding Protein Hfq   
CERTIFICATE OF EXAMINATION ......................................................................................... i 
Abstract ........................................................................................................................................ ii 
Acknowledgements ................................................................................................................... iii 
Table of Contents ...................................................................................................................... iv 
List of Tables .............................................................................................................................. vi 
List of Figures ........................................................................................................................... vii 
Chapter 1 - Introduction ................................................................................................................ 1 
1.1 Lateral gene transfer in bacterial populations: ............................................................... 1 
1.2 Transposons: ....................................................................................................................... 2 
1.3 Regulation of mobile elements: ........................................................................................ 5 
1.3.1 Regulation of transposase expression: .................................................................... 5 
1.3.2 Post translational regulation of transposons: .......................................................... 6 
1.4 Hfq and sRNAs: .................................................................................................................. 6 
1.5 Regulation of Hfq expression:......................................................................................... 12 
1.6 Cellular factors that affect Hfq levels: ............................................................................ 13 
1.7 IS1413: ............................................................................................................................... 15 
1.8 Tn10: ................................................................................................................................... 15 
1.9 Thesis topics addressed: ................................................................................................. 18 
Chapter 2 - Materials and Methods .......................................................................................... 20 
2.1 Bacterial strains used in this thesis: ............................................................................... 20 
2.2 Plasmids used in this thesis: ........................................................................................... 21 
2.3 Mating out assay: .............................................................................................................. 27 
2.4 Finding putative Hfq binding sites in IS Elements: ...................................................... 32 
2.5 β-Galactosidase assays:.................................................................................................. 32 
2.6 Hfq protein purification: .................................................................................................... 34 
2.7 In vitro transcription and RNA labeling: ......................................................................... 34 
2.8 Electrophoretic mobility shift assays: ............................................................................. 35 
2.9 RNA-sRNA basepairing predictions: ............................................................................. 36 
2.10 3’ RNA ligase-mediated rapid amplification of cDNA ends (3’ RLM-RACE): ........ 37 
2.11 Western blots: ................................................................................................................. 38 
 v 
2.12 Verification of sRNA induction: ..................................................................................... 39 
Chapter 3 - Results ..................................................................................................................... 41 
3.1 How common is the Hfq mediated repression of transposase expression in IS 
Elements? ................................................................................................................................. 41 
3.2 Hfq regulation of IS1413: ................................................................................................. 44 
3.3 Alternative pathways of IS10 regulation by Hfq at the 3' end of the mRNA 
transcript. .................................................................................................................................. 51 
3.4 Does Hfq bind the 3' end of IS10? ................................................................................. 57 
3.5 Does the BM1 mutation affect IS10 transposition frequency? .................................. 64 
3.6 Is the expression of RNA-IN regulated by an sRNA? ................................................. 68 
3.7 Does limiting the availability of Hfq proteins in E.coli impact on IS10 transposition 
frequency? ................................................................................................................................ 74 
Chapter 4 - Discussion ............................................................................................................... 84 
4.1 Using bioinformatics to identify IS Elements that are under Hfq regulation. ........... 84 
4.2 Hfq and IS1413 transposition: ........................................................................................ 86 
4.3 Hfq regulation of IS10 ...................................................................................................... 90 
4.4 RNA-IN has an Hfq binding site in the 3’ end and it may be relevant under certain 
physiological conditions. ........................................................................................................ 92 
4.5 Is IS10 transposition regulated by an sRNA ................................................................. 93 
4.6 Does modulation of Hfq levels have an impact on IS10 transposition? ................... 95 
Appendix 1- Obtaining a compiled list of IS Elements from the IS Finder database. ....... 99 
References ................................................................................................................................. 110 
 
 
 
 
 
 
 
 
 vi 
List of Tables 
Table 
TABLE 2.1 BACTERIAL STRAINS USED IN THIS THESIS……………….. 
Pg # 
21 
TABLE 2.2 PLASMIDS USED IN THIS THESIS…………………………...... 25-26 
TABLE 2.3 OLIGONUCLEOTIDES USED IN THIS STUDY……………….. 29-31 
TABLE 3.1 ELEMENTS IN THE IS FINDER DATABASE CONTAINING 
THE PREDICTED HFQ BINDING SEQUENCE AAYAAYAA……………… 
 
45 
TABLE 3.2 ELEMENTS IN THE IS FINDER DATABASE CONTAINING 
THE PREDICTED HFQ BINDING SEQUENCE AYAATAA………………... 
 
46 
TABLE 3.3 COMPILED SRNAS PREDICTED TO INTERACT WITH IS10 
ACCORDING TO INTARNA…………………………………………………… 
 
69 
TABLE 3.4 RATIOS OF TRANSPOSITION FREQUENCIES OF 
NK5830F’ AND ITS ISOGENIC MUTANTS………………………………….. 
 
79 
TABLE 3.5: RATIO OF TRANSPOSITION FREQUENCIES 
DETERMINED FROM A MATING OUT ASSAY AT ROOM 
TEMPERATURE WITH NO AERATION DIVIDED (STARVED) BY THE 
TRANSPOSITION FREQUENCY DETERMINED AT 37°C WITH 
AERATION (NORMAL)…………………………………………………………. 
 
 
 
 
81 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
List of Figures 
  
FIGURE Pg # 
FIGURE 1.1  MECHANISMS OF LATERAL GENE TRANSFER…………… 2 
FIGURE 1.2  THE DIFFERENCES BETWEEN INSERTION SEQUENCES, 
TRANSPOSONS AND COMPOSITE TRANSPOSONS…………………… 
 
4 
FIGURE 1.3  HFQ MODES OF ACTION………………………………………. 9 
FIGURE 1.4  FEATURES OF THE INSERTION SEQUENCE 1413……….. 14 
FIGURE 1.5  STRUCTURE OF Tn10 AND KEY SEQUENCES OF IS10R 17 
FIGURE 3.1  β-GALACTOSIDASE ACTIVITY FOR IS1413-LACZ 
TRANSLATIONAL FUSIONS…………………………………………………… 
 
49 
FIGURE 3.2  HFQ REPRESSES IS1413 TRANSPOSITION……………….. 52 
FIGURE 3.3  THREE PRIME RLM-RACE STUDIES SHOW THAT IS10 
TRANSCRIPTS FROM Tn10 HAVE DEFINED STOP POINTS, WITH NO 
INDICATION OF POLYADENYLATION OR RHO-INDEPENDENT 
TERMINATION SEQUENCES………………………………………………….. 
 
 
 
56 
FIGURE 3.4  IN-VITRO TRANSCRIPTION SCHEMATIC…………………… 58 
FIGURE 3.5  THE PROPOSED STRUCTURE FOR EACH OF THE RNA-
IN 3’ SPECIES……………………………………………………………………. 
 
60 
FIGURE 3.6  HFQ BINDS THE LAST 107 NUCLEOTIDES OF IS10 AND 
MUTATING THE SELEX SITE REDUCES BINDING………………………… 
 
62 
FIGURE 3.7  HFQ BINDS THE LAST 107 NUCLEOTIDES OF IS10 AND 
BINDING CAN BE COMPETED USING THE PROXIMAL BINDING SRNA 
DSRA OR DISTAL BINDING POLYA16……………………………………....... 
 
 
63 
FIGURE 3.8  THE BM1 MUTATION DOES NOT AFFECT 
TRANSPOSITION FREQUENCIES OF A HIGH COPY IS10 ELEMENT AS 
MEASURED BY A MATING OUT ASSAY…………………………………….. 
 
 
65 
FIGURE 3.9  β-GALACTOSIDASE ACTIVITY FOR IS10-LACZ  
TRANSLATIONAL  FUSIONS OF VARYING LENGTHS……………………. 
 
67 
FIGURE 3.10 PREDICTED REGIONS OF PAIRING BETWEEN sRNAS 
AND RNA-IN ACCORDING TO INTARNA…………………………………….. 
 
70 
FIGURE 3.11 PAIRING OF sRNAS TO IS10 (BP1-160) ONLY OCCURS  
WHEN IS10 IS IN EXCESS……………………………………………………... 
 
73 
FIGURE 3.12 HFQ BINDS GLMZ TO FORM 3 COMPLEXES……………… 74 
FIGURE 3.13 IPTG INDUCED MICC and GLMZ EXPRESSION…………… 76 
FIGURE 3.14 sRNA OVEREXPRESSION MATING OUT ASSAY…………. 77 
FIGURE 3.15 GROWTH CURVES OF NK5830 F’ AND ITS ISOGENIC 
MUTANTS…………………………………………………………………………. 
 
82 
FIGURE 3.16 WESTERN BLOTS OF NK5830F’ AND RPOS- 
CELL LYSATES…………………………………………………………………... 
 
83 
FIGURE 4.1  MODEL FOR POTENTIAL CONDITIONS THAT MAY 
CHANGE THE ABILITY FOR HFQ TO BIND A TRANSCRIPT……………... 
 
94 
  
 viii 
 
 
 
 
 
 
 
Abbreviation Meaning 
CRISPR Clustered Regularly Interspaced Short Palindromic 
Repeats 
DAM DNA Adenine Methyl Transferase 
DksA- NK5830F' (dska::tet) 
HBS Hfq binding site 
Hfq- NK5830F' (hfq-1::cat) 
I.E Inside End 
IHF Integrative Host Factor 
IR inverted repeat 
IS Insertion Sequences 
IS10L Left end of the IS10 sequence (codes a non-functional 
transposase) 
IS10R Right end of the IS10 sequence 
Mci multi-copy inhibition 
miRNAs micro RNA 
M-MuLV-RT Moloney Murine Leukemia Virus Reverse Transcriptase 
Normal Mating out conditions grown at 37°C with aeration 
O.E Outside End 
PAP Polyadenylate Polymerase I 
PNP Polynucleotide Phosphorylase 
PolyA Polyadenylation 
R Purine 
R Gene resistance gene 
RBS ribosome binding site 
RNA-IN IS10 Transposase mRNA 
RNA-OUT IS10 antisense-RNA 
RpoS- NK5830F' nlpD-rpoS::CmR 
siRNAs small interfering RNA 
sRNA small RNA 
Starved Mating out conditions grown at room temperature 
without aeration 
UTR untranslated region 
 1 
Chapter 1 - Introduction 
1.1 Lateral gene transfer in bacterial populations: 
 One of the driving forces of bacterial evolution is thought to be the ability to 
exchange DNA between populations via lateral gene transfer (reviewed in 1).  
Promiscuous DNA transfer can result in foreign genes being transferred from 
species to species, potentially conferring new survival traits in the recipient 
(including pathogenicity or antibiotic resistance) 1.  By analyzing the genome of 
E.coli MG1655 for DNA with different base compositions and different codon 
bias, Lawrence et al. inferred that 17.6% of open reading frames of the genome 
were acquired from at least 234 lateral gene transfer events 2.  Mechanisms of 
lateral gene transfer include transduction, conjugation and transformation (See 
Figure 1.1).  Transduction involves a bacteriophage incorporating some host 
DNA into its capsid and upon infection, incorporating it into the recipient’s 
genome.  Transformation entails the uptake of DNA from the environment.  
Conjugation refers to bacteria transferring self-mobilizing plasmids through sex 
pili from one cell to another.  Conjugation can occur between bacteria, bacteria 
and plants 3, or bacteria and yeast 4, increasing the diversity of transmissible 
genes.  Transposons are often carriers of antibiotic resistance genes; their ability 
to transpose onto phage or self-transmissible plasmids make them a major 
component in lateral gene transfer 5. 
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1.2 Transposons: 
 
 Many bacteria carry DNA transposons which are mobile genetic elements 
that can move to various loci throughout the genome.  Transposition events can 
have consequences on the host such as gene deletions, inversions 6 and gene 
activation 7.   
Figure 1.1 Mechanisms of lateral gene transfer.  Transduction involves a 
bacteriophage injecting its genetic material into a recipient bacterial cell.  
Transformation involves the cellular uptake of DNA from the environment.  
Conjugation involves the active transfer of DNA from one cell to another through 
a sex pilus. 
 
  
 3 
There are three major classes of mobile genetic elements found in 
bacteria: Insertion sequences (IS Elements), composite transposons, and 
conjugative transposons (see Figure 1.2).  IS Elements (top of Figure 1.2) are 
comprised of genes necessary to facilitate their own mobility, such as a 
transposase.  Many IS Elements are flanked by inverted repeats which often act 
as the boundaries of the IS Element and the transposase binding region.  When 
two IS Elements flank a common genomic region they can form a composite 
transposon (bottom of Figure 1.2).  The two IS Elements of the composite 
transposon may or may not be completely identical; however, as long as one of 
the IS Elements encodes a functional transposase, the entire composite 
transposon can move as a single unit.  Conjugative transposons are larger 
mobile elements than IS Elements and composite transposons (middle of Figure 
1.2).  Conjugative transposons, such as Tn914, encode genes required for cell-
to-cell transfer, an integrase for integration into the chromosome, an excisionase 
which excises the element from the host’s chromosome and often antibiotic 
resistance genes such as tetracycline (reviewed in 8).  The abundance of IS 
Elements in a genome is exemplified with the 37 IS Elements present in E.coli 
MG1655 2.  Mobile genetic elements are also very prevalent in Burkholderia 
cephacia, where the study of catabolite gene activation by IS Elements has been 
extensively studied 9.  Overall, the abundance of mobile genetic elements in 
bacterial genomes may play a role in changing the overall architecture of the host 
over time and may confer survival advantage to the host in times of 
environmental stresses.  The tetracycline carrying conjugative transposon 
CTnDot is an example of a mobile genetic element playing a role in stress 
 4 
adaptation.  Upon exposure to tetracycline, the rates of CTnDOT excision from 
the host chromosome increases 10. 
 
Figure 1.2 The differences between insertion sequences, transposons and 
composite transposons.  Top: Insertion Sequences (IS Elements) are DNA 
sequences that only encode genes involved in their mobilization (such as a 
transposase).  Many (but not all) IS Elements are flanked by inverted repeats 
which act as the IS Elements’ boundary and often serve as the binding regions 
for the transposase.  Middle: Conjugative transposons are much larger than IS 
Elements and contain gene clusters of similar function.  Conjugation genes (light 
blue) are involved in the transfer of the excised circular form of the transposon to 
a recipient cell.  Antibiotic resistance genes (R Gene) can also be carried within 
the transposon (orange).  Regulatory genes (brown) are often general 
transcription factors involved in regulating the expression of the element’s own 
genes.  Excisionase (dark blue) is involved in excising the element from the 
host’s chromosome to allow the element to circularize into its transmissible form.  
The integrase genes are involved in integrating the element into the bacterial 
chromosome.  Bottom: A composite transposon is made when two IS Elements 
mobilize to a genomic region within close proximity to one another.  The region 
that is trapped between the two IS Elements becomes part of the mobile element 
when the transposase binds the outer boundaries of the composite transposon.  
Often the genomic region between the two IS Elements is often an R Gene, or 
another survival enhancing trait. 
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1.3 Regulation of mobile elements: 
 Mobile genetic elements depend on the survival of the host to maintain 
their existence.  With host gene rearrangements and deletions being possible 
consequences of transposition, mobile genetic elements are under tight 
regulation by both the host and the mobile genetic elements themselves to 
maintain the viability of both.  Ultimately, the frequencies of transposition are 
dependent on the amount of transposase (the enzyme responsible for element 
mobilization) present in the cell 11.  Down regulation of the transposase at the 
expression level and transposon-binding level makes transposition events a rare 
occurrence.  For example, IS10 transposes at a rate of 10-4 events per cell 
generation 12, and Tn10 has an even lower transposition rate of 10-7 events per 
cell generation 13.   
1.3.1 Regulation of transposase expression: 
Transposons and IS Elements are often poorly expressed from moderate 
endogenous promoters coupled with suboptimal ribosome binding sites 14, 
resulting in small amounts of transposase available in the cell to perform the 
transposition reaction.  Transcription levels of transposases can also be affected 
by host factors.  For example, DNA Adenine Methyltransferase (DAM) in E.coli 
down regulates IS10 transposase expression at the transcriptional level through 
the methylation of an adenine within the -10 region of the promoter, resulting in 
reduced promoter activity 15.  Anti-sense RNAs can also regulate transposon 
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expression, such as in IS10/Tn10, where an anti-sense RNA (RNA-OUT) base 
pairs with the transposase mRNA (RNA-IN) resulting in the occlusion of the RBS.   
1.3.2 Post translational regulation of transposons: 
Host factors can also play a role on mobilization of transposons at a post 
translational level.  Host factors play an important role in the regulation of 
transposition (reviewed in 16).  Tn10 is both positively and negatively regulated by 
host factors.  DAM, in addition to regulating IS10 transcription, also methylates an 
adenine found within the inside end of IS10 which reduces transposase binding 
15.  Another host factor, Integration Host Factor, positively regulates Tn10 
transposition through binding the transposon ends promoting the formation of the 
paired ends complex (a step in IS10/Tn10 transposition) 17.  The host factor Hfq 
has also been implicated in IS10 regulation; E. coli strains with a hfq gene 
disruptions (Hfq-) show a 50-86 fold increase in IS10 transposition when IS10 is 
on a multi-copy plasmid, compared to cells with functional Hfq 18.   
1.4 Hfq and sRNAs: 
Hfq is an RNA binding protein that forms a homo-hexameric ring from 11.2 
kDa monomers 19.  It is a member of the SM/LSM family of proteins, containing 
the SM1 motif found in Eukaryotic SM and LSM proteins 20 .  In Eukaryotes, SM 
and LSM proteins are involved in DNA and RNA processing events such as pre-
mRNA splicing and telomere synthesis 21.  In bacteria, Hfq is a key component in 
small RNA (sRNA) regulation in bacteria.  One of the more defined roles of Hfq is 
in promoting pairing of trans-encoded sRNAs with their targets.  Recently, Hfq 
 7 
has been shown to be involved in accelerating the rate of pairing a cis-encoded 
sRNA (IS10’s RNA-OUT) to RNA-IN in vitro18.  Both trans-encoded and cis-
encoded sRNAs are analogous to Eukaryotic micro RNAs (miRNAs) and small 
interfering RNAs (siRNAs) in that they can alter the expression of their mRNA 
targets through RNA destabilization or translation inhibition 22.   
Hfq can affect RNA molecules in at least 6 different ways (see Figure 1.3).  
Firstly, Hfq can act in conjunction with an sRNA to block the ribosome binding 
site (RBS) on its target mRNA which results in translation inhibition.  In this case, 
it is thought that Hfq acts to either promote pairing of the two RNA species 
through binding and secondary structure alteration, or by physically increasing 
the local concentrations of the two RNA species 23 (Figure 1.3A).  RBS blocking 
by an sRNA and Hfq is found in the regulation of fhl translation (an mRNA coding 
for a transcriptional activator involved in the formate pathway in Enterobacteria) 
by the sRNA OxyS; in this system, the OxyS binding site overlaps the RBS.  
Upon binding to the fhl mRNA, OxyS directly competes with the 30S ribosomal 
subunit for binding in an Hfq dependent manner 24.  Secondly, Hfq and sRNAs 
can actually increase translation initiation as well.  An example of this is found in 
the study of the DsrA:RpoS interaction.  RpoS mRNA contains a secondary 
structure in its 5’ UTR that results in the occlusion of the RBS.  DsrA relieves this 
secondary structure by pairing RpoS mRNA in an Hfq dependent manner making 
the ribosome binding site accessible and allowing for ribosome binding 25 (Figure 
1.3C).  Thirdly, Hfq can also directly target the RBS of mRNA independent of an 
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sRNA, which in turn has a destabilizing effect on the half-life of the mRNA and 
reduced translation (Figure 1.3B). 
 RNA stability which is affected by the frequency of translation initiation on 
an mRNA by the 16S ribosomal subunit, and the initiator tRNA 26.  A reduced 
frequency of translation initiation results in reduced mRNA levels in the cell 26.  
This is exemplified in the mRNA ompA, a message for an outer membrane 
protein, where Vytvytska et al show Hfq can bind to ompA mRNA, preventing the 
initiator complex from forming and ultimately making the mRNA vulnerable to 
RNase E mediated degradation 27.  Hfq is not just a promoter of RNA 
degradation; in a fourth mechanism Hfq can also protect sRNAs from RNases by 
blocking cleavage sites (Figure 1.3 F).  For example, the sRNAs DsrA and RhyB 
are protected from RNase E cleavage when Hfq binds and protects the RNase E 
cleavage site on the sRNAs 28.  In the fifth mechanism of how Hfq can affect 
RNA, Hfq facilitated pairings of sRNAs can result in the degradation of both the 
sRNA and target mRNA (Figure 1.3D).  A study by Massé et al demonstrates 
that in the Hfq facilitated binding of the sRNA RhyB to the mRNA sodB, both RNA 
species are degraded in an RNase E dependent manner 29.  A sixth proposed 
mechanism of Hfq is its involvement in the polyadenylation of mRNA transcripts 
(Figure 1.3E).  In a study by Mohanty et al, total cellular RNA from log phase E. 
coli was analyzed for polyAdenylated (polyA) tail length; Hfq disruptions resulted 
in a decrease in polyA tail length of greater than 20 nucleotides 30.  A 
consequence of polyadenylation of mRNA in E.coli is the decrease of mRNA 
stability 31.   
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Figure 1.3 Hfq modes of action.  A) Hfq and an sRNA can bind the ribosome 
binding site (RBS) of a target mRNA and inhibit translation.  B) Hfq can directly 
bind the ribosome binding site of an mRNA preventing the 30S ribosomal subunit 
from binding.  C) Hfq and an sRNA can positively regulate translation by altering 
the secondary structure of an mRNA that is self-occluding the RBS.  D) RNase E 
can associate with Hfq’s C-terminus and degrade mRNA that the Hfq:sRNA 
binary complex is base paired with.  E) Hfq can recruit poly(A) polymerase to the 
3’ end of an mRNA, resulting in polyadenylation and subsequent destabilization 
of the transcript.  F) Hfq can directly bind sRNAs and protect them from 
degradation 
The impact of Hfq and sRNAs on gene regulation in bacteria is becoming 
apparent.  To date, there are numerous classes of regulatory RNAs, including: 
cis-encoded RNAs encoded on the opposite stand of the mRNA, trans-encoded 
sRNAs which are often found in intergenic regions of the genome , and Clustered 
Regularly Interspaced Short Palindromic Repeats (CRISPR) RNAs (reviewed in 
22).  These 3 subclasses of small RNAs are transcribed from different parts of a 
bacterial genome and have different mechanisms of action.  Cis-encoded RNAs 
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are encoded from the opposite DNA strand that codes for the mRNA, so they 
have perfect complementarity to a region of their target mRNA (reviewed in 32).  
Trans-encoded sRNAs are often encoded in intergenic regions of the genome 
and can have multiple targets with limited complementarity; many trans-encoded 
sRNAs are dependent on Hfq to effectively basepair with their target mRNA 
(reviewed in 22).  CRISPR RNAs are found clustered in 1 or 2 loci of a bacterial 
genome and are thought to protect the cell from phage infection; research into 
the mechanism of action these CRISPR RNAs is still in preliminary stages 
(reviewed in 33).   
The first cis-encoded sRNA reported to regulate a transposon was the 
RNA-OUT transcript of Tn10 34.  RNA-OUT is an anti-sense RNA that base pairs 
with RNA-IN (the transposase mRNA) ultimately resulting in the occlusion of the 
ribosome binding site and start codon, leading to reduced transposase 
expression 34.  Hfq may be involved in pairing of IS10’s RNA-IN and RNA-OUT 18 
by increasing the half-life of RNA-OUT, by altering the secondary structure of the 
two RNA species making pairing more favourable or by increasing the local 
concentrations of the two RNA species making binding more probable.  Other 
examples of cis-encoded RNA control have since been identified and 
characterized.  An interesting study that found a connection between cis and 
trans-encoded sRNAs was on the luxS mRNA and its interaction with the sRNA 
MicA.  MicA interacts with OmpA as a trans-sRNA; MicA is also a cis-encoded 
sRNA that, upon pairing with its target mRNA luxS, results in a processed 
transcript 35.  This interaction suggests that cis-encoded sRNAs may act on more 
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targets than their perfectly complementary partner mRNA and thus could be 
regulating a multitude of mRNAs by acting as a trans-sRNA as well.  Generally, 
Hfq is not thought to be required for cis-encoded RNAs to pair with their target 
mRNA.  However, Hfq’s role in sRNA stability suggests that Hfq may be required 
for these sRNAs to have sufficient stabilities in vivo to act on their targets. 
Trans-encoded sRNAs in E.coli are encoded from regions distant from their 
numerous targets.  Trans-encoded sRNAs are frequently expressed in response 
to stress stimuli to the cell which can include oxidative stress (which induces the 
sRNA OxyS) 36 or low temperature growth (which induces the sRNA MicC) 37.  
Trans-encoded sRNAs often require the RNA binding protein Hfq to promote 
pairing to their mRNA targets 38.  A well characterized sRNA:mRNA pairing 
reaction is between the sRNA GlmZ and the glmS mRNA (which encodes an 
enzyme involved in glucosamine-6-phosphate synthesis) 39.  Without the 
activating sRNA glmZ, the 5’ untranslated region of the glmS RNA forms a hairpin 
occluding the ribosome binding site; Hfq binds to both GlmZ and glmS RNA 
species.  GlmZ binds to glmS mRNA upstream of the Shine-Dalgarno in an Hfq 
dependent manner, resulting in an secondary structure change of the mRNA and 
an available ribosome binding site 39.  Overall, sRNAs allow the cell to quickly 
respond to cellular stresses through a network of sRNAs without the need to 
invest energy in regulatory proteins.  Given that there is still a 7-fold increase in 
transposition in the absence of Hfq and the anti-sense RNA-OUT, there may be 
yet another undiscovered RNA-Hfq interaction involved in down regulating IS10 
transposition such as an endogenous sRNA interacting with RNA-IN. 
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The Hfq hexamer has two distinct RNA binding surfaces, known as the 
proximal and distal faces (reviewed in 40).  The two different faces of the Hfq 
hexamer are thought to bind different RNA sequences with the proximal face 
binding polyA/U sequences and the distal face binding sequences rich in the 
sequence ARNx (where R is a purine and N represents any nucleotide)41.  Hfq is 
also able to bind DNA in a sequence independent manner 42.  Physiological 
concentrations of Hfq favour hexameric and multimeric forms of Hfq; the 
hexameric form is the active RNA and DNA binding form of the protein43.  A study 
utilizing Genomic systematic evolution of ligands by exponential 
enrichment (SELEX) identified additional sequences that Hfq bound with high 
affinity: AAYAAYAA and AYAAUAA 44. 
1.5 Regulation of Hfq expression: 
Transcription of hfq is driven from 3 promoters (two σ70-dependent and 
one σ 35-dependent) from the hfq operon 45.  Hfq self-regulates the amount of hfq 
transcripts in the cell though the binding and destabilization of its mRNA in 
exponentially growing cells 46.  Hfq also self regulates its own translation by 
binding to its own mRNA 47.  Regardless of such regulation, Hfq remains 
abundant in the exponentially growing cell with estimates ranging from 2500 
molecules of monomer per cell 48 to 55,000 molecules of monomer per cell 49.  
Deletions and disruptions of hfq result in shorter half-lives of small RNAs (sRNA) 
28, pleiotropic responses to cellular stress 50, and increased transposition of 
Tn10/IS10.  Tn5 transposition frequencies also increase in cells lacking functional 
Hfq 51.   
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1.6 Cellular factors that affect Hfq levels: 
Recent studies by Hussein et al. and Moon et al. have shown that 
overexpression of sRNAs can result in a titration effect on cellular Hfq 
concentration.  Most cellular Hfq is already bound to nucleic acids with 80-90% of 
cellular Hfq associated with ribosomes and 10-20% being found in the nucleoid 
52.  Further depleting the pool of free cellular Hfq may result in the expression of 
genes that are normally repressed by Hfq thus allowing the cell to mount a quick 
response to cellular stress 53,54.  DksA is a transcription factor that responds to 
amino acid starvation conditions in conjunction with ppGpp, which modulates 
RNA polymerase activity; dksA deletion strains in E.coli and Shigella flexneri 
reduce Hfq protein levels by 50% 54,55.  Another cellular stress that results in 
reduced Hfq levels, is the transition between exponential phase to stationary 
phase which results in a 33% reduction of Hfq protein levels 49.   
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Figure 1.4 Features of IS1413: IS1413 contains two flanking inverted repeats (denoted IR Left and IR Right) 
denoting the boundaries of the element.  The +1* represents the transcriptional start based on 5’ RACE data (lab 
data).  The predicted start codon is found at bp 120.  The … represents a break in the sequence.  The stop codon 
is denoted in red at bp 1391.  A predicted Hfq binding site is bolded and denoted HBS using the predicted Hfq 
binding aptamer (AAYAAYAA) 44.  The IR Right portion of IS1413 contains a sequence TTGACG denoted -35* 
which can act as the -35 portion of an E.coli promoter when inserting in front of another gene. 
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1.7 IS1413: 
IS1413 is an IS Element (Figure 1.) originally identified in Burkholderia 
cephacia AC1100 (now known as Burkholderia phenoliruptrix) which was found 
to occasionally create a promoter fusion with a promoterless streptomycin gene 
56.  The promoter fusion occurs by the -35 sequence found in the right IR 
sequence (Figure 1., shadowed text) inserting in front of a gene with a sequence 
resembling the -10 region of a promoter.  There are 10 to 12 copies of IS1413 in 
the genome 56 and very little is known about the mechanism of transposition or its 
regulation.  IS1413 was discovered by its 83% similarity to IS1490 (the IS 
element thought to be responsible for Burkholderia phenoltripix’s  ability to break 
down DDT) 56.  IS1413 contains a perfect match for a potential Hfq binding site 
(HBS) within its 5’ untranslated region (UTR) (Figure 1.).  This Hfq binding site 
may be indicative of a regulatory mechanism of IS1413 that involves Hfq. 
1.8 Tn10: 
Tn10 is a well-studied transposon that confers tetracycline resistance to its 
host.  Tn10 is a composite transposon comprised of two IS10 copies (IS10L and 
IS10R) flanking tetracycline resistance genes (Figure 1.).  IS10R is a functional 
IS element that can mobilize either as an IS element when the transposase acts 
at its inside and outside ends (Figure 1.), or mobilize the entire Tn10 element 
when the transposase acts at the two outside ends.  IS10L is a degenerate copy 
of IS10 and does not encode a functional transposase 57.  The expression of 
IS10’s transposase is under tight regulation from host factors and an antisense 
RNA system.  The antisense RNA system is self-encoded in the IS10R 
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transposase gene which encodes two RNA species (Figure 1.); RNA-IN (the 
mRNA of the IS10 transposase) and RNA-OUT (an anti-sense RNA that contains 
35 bases that are complementary to the 5’ region of RNA-IN)34.  Pairing of RNA-
IN and RNA-OUT results in the occlusion of the ribosome binding site of RNA-IN 
58 and an RNase II dependent decrease in the half-life of RNA-IN 59.  The anti-
sense control is of particular importance when multiple copies of IS10 are 
expressed.  When expressing IS10 on a multi-copy plasmid, the transposition 
frequency of a single chromosomal copy of Tn10 decreases by about 20 fold 34.  
This effect is known as multi-copy inhibition (mci).  The mci effect can be 
explained by the transposase encoded by RNA-IN being most effective when 
acting on sequences close to where it was synthesized 13, in contrast to RNA-
OUT which can freely distribute through the cell.  Furthermore, RNA-IN levels are 
less than 1% that of RNA-OUT 11.  The differences in RNA-IN and RNA-OUT 
levels are due to RNA-OUT having a stronger promoter than RNA-IN and RNA-
OUT having a longer half-life than RNA-IN (70 minutes versus 40 seconds, 
respectively) 11. 
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Figure 1.5 Structure of Tn10 and key sequences of IS10R.  O.E and I.E are 
the outside ends and inside ends respectively.  The IS10R encoded transposase 
binds to the I.E and O.E.  RNA-IN (the transposase mRNA) starts at the G 
denoted in purple.  The ribosome binding site (RBS) of RNA-IN is denoted in blue 
and the translational start denoted in green.  Downstream towards the 3’ region 
of RNA-IN is a predicted Hfq binding site (HBS).  The translational stop codon is 
denoted in red within the I.E.  RNA-OUT is the antisense RNA and is denoted in 
the shadowed text.  RNA-OUT is transcribed from the opposite DNA strand of 
RNA-IN. 
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1.9 Thesis topics addressed: 
 Transposons are heavily regulated by host factors.  Hfq is a host factor 
that negatively regulates IS10/Tn10 and IS50/Tn5.  Hfq may be a global regulator 
of many IS Elements.  An RNA interference mechanism has already been 
characterized in Eukaryotes that repress mobile genetic elements such as 
viruses and transposable elements.  Small interfering RNAs (siRNAs) and 
microRNAs (miRNAs) are two defense mechanisms eukaryotes use to silence 
genes (including transposons and viral genes); siRNAs result in the cleavage of a 
target mRNA and miRNAs result in repressed translation or sometimes cleavage 
of the target mRNA (reviewed in 60,61).  Perhaps sRNAs could be functioning as a 
Prokaryotic method of silencing transposable elements.  Tn10/IS10 and Tn5/IS50 
have already been shown to be repressed by Hfq which is closely connected to 
the sRNA regulation in Bacteria.  In this thesis I follow up on three main 
questions: 
1) Can transposons that are subject to Hfq dependent regulation be identified 
by searching for putative Hfq binding sites in the transposase transcript? 
2) Is an endogenous E.coli sRNA involved in Hfq-mediated regulation of 
Tn10/IS10 transposition? 
3) Does limiting the amount of synthesis or availability of Hfq influence 
Tn10/IS10 transposition? 
In this work I explored the effects Hfq has on the regulation of the two IS 
Elements IS10 and IS1413 which were identified by searching for putative Hfq 
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binding sites in the IS Finder database.  IS10 contains an Hfq binding site in its 3’ 
region, however disrupting this Hfq binding site through mutation does not result 
in a de-repression of Hfq in a transposition assay.  IS1413 has an Hfq binding 
site found within its 5’ untranslated region and for the first time I show it can 
undergo transposition in E.coli at an average frequency of 3.7 x 10-5 ± 7.8 x 10-5 
in the presence of Hfq and increases its average transposition frequency to 5.0 x 
10-4 ± 3.8 x 10-4 in the absence of Hfq.  I also identified that IS10 transposition 
increases in wildtype cells by 9.81 ±1.64 fold when cells are starved and put 
under non-aerating conditions.  Finally I analyzed the 3’ region of IS10 to 
determine where the transcript terminates and looked for a potential mechanism 
in which Hfq could be acting on the RNA (such as facilitating polyadenylation).  A 
defined stop point which appears to either be due to a processing event or run off 
transcription was found using the 3’ RACE technique. 
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Chapter 2 - Materials and Methods 
2.1 Bacterial strains used in this thesis: 
 All bacterial strains (E.coli and Burkholderia) used in this thesis are 
compiled in Table 2.1.  All plasmids used in this study are compiled in Table 2.2.  
Bacterial strains with gene disruptions were made via generalized transduction.  
Phage P1 was used for generalized transduction 62.  P1 Phage was used to infect 
E. coli cells containing a “marked” gene of interest (containing an antibiotic 
resistance gene).  A culture of E.coli containing the “marked” gene was grown 
overnight in LB broth with selection and subcultured in the absence of antibiotic 
but supplemented with 25 mM MgCl2, 5 mM CaCl2, and 0.2% glucose to grow to 
early log phase.  Forty μL of P1 phage were added to the subculture of cells, and 
further incubated for 3 hours at 37°C with aeration.  Fifty μL of chloroform was 
added to the infected cells, vortexed, and centrifuged at 6000 rcm for 5 minutes.  
The supernatant was removed and stored at 4°C.  Phage lysate was titred to a 
multiplicity of infection of 1-5 plaque forming units/cell.  NK5830 F’ cells 
transformed with a temperature sensitive plasmid encoding recA (pET001) were 
grown in LB broth overnight at 30°C with aeration.  Cells were subcultured (1:20) 
in LB broth containing 25 mM MgCl2, 5 mM CaCl2, and 0.2% glucose at 30°C with 
aeration and grown to exponential phase.  Cells and phage lysate were mixed at 
a 1:1 ratio (100 μL of exponentially growing cells (undiluted, diluted by a factor of 
10, or diluted by a factor of 100) and 100 μL of phage lysate) and incubated at 
30°C for 60 minutes.  Two-hundred microlitres of 1 M sodium citrate (pH 5.5) was 
added to the transduction mix, followed by 1 mL of LB broth.  Cells were 
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incubated at 37°C with aeration for 60 minutes, spun down at 6000 rcm for 5 
minutes and resuspended in 0.85% NaCl in H2O.  Cells were plated on LB agar 
containing 20 μg/mL of chloramphenicol and incubated at 37°C.  Individual cells 
picked from overnight plates and were serially passaged on LB agar containing 
either 20 μg/mL of chloramphenicol as well as LB agar plates containing 100 
μg/mL of ampicillin (to ensure the recA plasmid was lost) until colonies were 
cured of the recA containing plasmid pET001. 
Table 2.1 Bacterial strains used in this thesis 
Strain Description Source/ 
Reference 
NK5830 F' recA56 su° lacproXII1, Arg
-, Ara-, NalR, 
RifR/F’ laciq  L8 pro 
63 
DBH16 NK5830F' transduced to hfq-1::Cm 
18 
DBH48 NK5830F' Transduced to rpoS::cat (phage 
from NM22542 ΔnlpD-rpoS CmR) 
(Laboratory 
stock) 
DBH144 Burkholderia phenoliruptix AC1100 (Gift 
from Dr.  Zlosnik ) 
A Gift from Dr.  
Zlosnik (UBC) 
DBH174 NK5830 ΔdksA::Tet (using phage lysate 
from MG1655 ΔdksA::Tet from M.Cashel via 
S Gottesman (CF9239) 
This Study 
DBH 181 NK5830Δ SroG::IS50-Kan-LacZ Laboratory stock 
HB101 F-, leu- ; StrR  64 
 
2.2 Plasmids used in this thesis: 
 All plasmids used in this thesis are compiled in Table 2.2. Plasmids 
pDH694-696 are pACYC184 derivatives; they contain pLlacO1 inducible sRNAs 
(DsrA. MicC, and RhyB respectively).  These sRNA inducible plasmids were 
constructed by PCR amplifying DsrA, MicC or RhyB from a genomic preparation 
of NK5830 DNA using primer pairs BM43A and BM44A for DsrA, BM41A and 
 22 
BM42A for MicC and BM40A and BM39A for RhyB.  PCR products were digested 
using Nco I and Xmn I and cloned into Nco I/Xmn I digested pACYC184 plasmid.  
For DsrA, MicC and DsrA PCR reactions the reaction conditions were as follows: 
Genomic DNA preparations of NK5830 were done using the GenElute™ 
Bacterial Genomic DNA Kit (Sigma) following the manufacterer’s protocol.  PCR 
reactions were the same for all three pLlacO1 inducible sRNAs.  Reactions 
consisted of 10 ng of NK5830F’ gDNA,, the sRNA respective forward and reverse 
primers [1 μM each], combined with GoTaq Mastermix (Promega) [1x].  PCR 
conditions were: 98°C (2 min) for the initial denaturation, followed by 98°C (30s), 
65°C (40s), and 72°C (1 min) repeated 30 times.  A final extension step was done 
at 72°C for 5 min.  The resulting amplicon was gel purified using the QIAEX II Gel 
Extraction Kit (Qiagen).   
The new IS10-Kan construct pDH725 and the BM1 mutant pDH734 were 
generated by PCR amplifying IS10 on pDH669 (for WT) or pDH703 (for BM1 
Mutant) from bp1 to the end of the stop codon at bp1316 using primers BM27A 
and BM26A.  Reactions consisted of 10 ng of template (pDH669 or pDH703), 
forward and reverse primers [1 μM each], combined with GoTaq Mastermix 
(Promega) [1x].  PCR conditions were: 98°C (2 min) for the initial denaturation, 
followed by 98°C (30s), 62.2°C (45s), and 72°C (2 min) repeated 35 times.  A 
final extension step was done at 72°C for 5 min.  The resulting amplicon was gel 
purified using the QIAEX II Gel Extraction Kit (Qiagen).  This IS10 amplicon was 
cloned into pGEM-T-Easy (Promega).  The kanamycin gene containing IS10’s 
inside end was PCR amplified from pDH502 using the primers BM23A and 
BM22A.  The BM22A primer contains 27 bases of IS10’s inside end (IS10 I.E), 5’ 
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to the complementary sequence of the kanamycin gene.  PCR reactions 
consisted of 10 ng of template (pDH502), forward and reverse primers [1 μM 
each], combined with GoTaq Mastermix (Promega) [1x].  PCR conditions were: 
98°C (2 min) for the initial denaturation, followed by 98°C (30s), 55°C (45s), and 
72°C (2 min) repeated 5 times.  Another set of PCR parameters of 98°C (30s), 
68°C (45s), and 72°C (2 min) was then followed for 30 cycles: A final extension 
step was done at 72°C for 5 min.  The resulting amplicon was gel purified using 
the QIAEX II Gel Extraction Kit (Qiagen).This kanamycin-IS10 I.E amplicon was 
digested with Spe I and Xba I and cloned into the IS10-containing pGEM -T-easy 
construct digested with Spe I.   
The LacZ translational fusion plasmids pDH703 and 704 were made 
through site directed mutagenesis of pDH669.  For pDH703 primers BM10A and 
BM11A were used with pDH669 and Pfu polymerase (Stratagene) according to 
manufacturer’s guidelines for site-directed mutagenesis.  For pDH704 primers 
BM12A and BM13A were used with pDH669 and Pfu polymerase (Stratagene) 
according to manufacturer’s guidelines for site-directed mutagenesis 
The pDH734 (IS10-Kan BM1 mutation) was constructed by PCR 
amplifying the IS10 fragment on pDH703 with primers BM26A and BM18A.  PCR 
reactions consisted of 10 ng of template (pDH703), forward and reverse primers 
[1 μM each], combined with GoTaq Mastermix (Promega) [1x].  PCR conditions 
were: 98°C (2 min) for the initial denaturation, followed by 98°C (30s), 62.2°C 
(45s), and 72°C (2 min) repeated 25 times.  A final extension step was done at 
72°C for 5 min.  The resulting amplicon was cloned into pGEM T-easy vector 
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(Promega).  The construct was digested with SpeI and the gel purified using the 
QIAEX II Gel Extraction Kit (Qiagen). 
The IS1413 containing plasmid pDH735 was constructed by PCR 
amplifying IS1413 from a genomic DNA preparation from Burkholderia 
phenoltripix AC1100 using primers BM1A and BM2A.  The Taq polymerase 
amplified amplicon was cloned into pGEM T-easy (Promega).  The mutated 
IS1413 LacZ translational fusion plasmids pDH760 and pDH794 were both made 
by amplifying the IS1413 portion of pDH757.  The forward primers BM4A and 
BM3A contain a Nhe I cut site as well as the IS1413 SELEX mutations C and B 
respectively (see Figure 3.1B).  The reverse primer used to amplify IS1413 for 
LacZ translational fusions was BM5A which contains a Sph I cut site.  Amplicons 
of IS1413 mutants B and C were digested with Nhe I and Sph I and cloned into a 
Nhe I/Sph I digested pBad 24 vector.  The kanamycin ‘marked’ IS1413 construct 
pDH797, was made by first doing site-directed mutagenesis on IS1413 using 
primers BM1A and BM7A with pDH735 as a template to introduce a Xho I cut site 
after the stop codon in the IS1413 transposase gene.  The resulting amplicon 
contained a truncated IS1413 (missing 27 nucleotides), to rectify this, the Xho I 
containing amplicon was used as a template for another PCR reaction using 
BM1A and BM6A primers.  The resulting amplicon was a full length IS1413 
sequence containing a Xho I cut site and was cloned into pGEM-T Easy 
(Promega) to make pDH796.   
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Table 2.2 Plasmids used in this thesis. 
Plasmid Description Source or 
Reference 
pDH502 pBR322-hISG1::IS10KAn (pNK1219) 65 
pDH602 pACYC184- HisG1::IS10Kan 18 
pDH662 1-121 IS10 translational fusion to the 9
th codon of LacZ  Unpublished, a 
gift from C.  Jain 
pDH663 1-180 IS10 translational fusion to the 9
th codon of LacZ Unpublished, a 
gift from C.  Jain 
pDH664 1-290 IS10 translational fusion to the 9
th codon of LacZ Unpublished, a 
gift from C.  Jain 
pDH668 1-1020 IS10 translational fusion to the 9
th codon of LacZ Unpublished, a 
gift from C.  Jain 
pDH669 1-1320 IS10 translational fusion to the 9
th codon of LacZ Unpublished, a 
gift from C.  Jain 
pDH676 Tn10 in a broad host range plasmid (pBE10) 66 
pDH694 pACYC184 encoding pLlacO-1 promoter driving expression of DsrA (as a pcr fragment 
cloned into Nco I/Xmn I-cut pACYC184) 
This Study 
pDH695 Same as 694 but with MicC This Study 
pDH696 Same as 695 but with RyhB This Study 
pDH703 pDH669 containing the BM1 mutation This Study 
pDH704 pDH669 containing the BM2 mutation This Study 
pDH725 Kanamycin marked IS10 with no repeated sequence This Study 
pDH734 pDH725 with a mutated putative Hfq binding site Tyr 374 TACTAT (found just outside 
of the SELEX site) and an Arg 378 AGG CGG  
This Study 
pDH735 IS1413 in pGEM T-easy This Study  
pDH757 IS1413 (up to bp 445) lacking -10/-35 ligated into MCS of pBAD24 ampR Morgan Black’s 
Fourth Year 
Thesis 
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pDH760 IS1413-LacZ (from 757) lacking native promoter sequence with a mutated Hfq binding 
site (GAACACCAA) cloned into MCS (NheI/SphI) of pBAD24 
This Study 
pDH794 Same as pDH760 only SELEX mutation = TAAACTACAA This Study 
pDH796 1413 in pGEM mutations at A1397C,T1402G to make a XhoI cut This Study 
pDH797 Sph I-Kan-Sph I PCR product (from 602) cloned into pDH796 Xho I site This Study  
pDH763 Empty pLlacO1 vector (pBR322 derivative 67 
pDH783 plLac-GlmZ (pBR322 derivative) 67 
pET001 pRR10-ts97-derived recA; temperature-sensitive plasmid; AmpR 68 
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A kanamycin resistance gene was amplified from pDH502 using primers 
BM24A and BM25A.  The resulting amplicon was digested with Sph I and cloned 
into the Xba I site of pDH796 to make pDH797. 
2.3 Mating out assay: 
For the mating out assays, NK5830 F’ and its isogenic mutant, Hfq-, RpoS-, 
H-NS-, or DksA-, derivatives were used as donors and HB101 as the recipient.  
IS10/IS1413-Kan encoding plasmids (pDH502, pDH602, pDH725, pDH734, or 
pDH797) were transformed into donor strains through electroporation and 
transformants were selected for on LB plates containing kanamycin [25 μg/mL].  
Under normal circumstances (Normal Mating Out), overnight cultures of donor 
cells were grown overnight at 37°C with aeration to saturation in LB broth 
containing kanamycin [25 μg/mL].  Overnight cultures were subcultured in LB 
broth in the absence of antibiotics.  For the mating out assay under starvation 
conditions (Starved), donor cells were grown at room temperature (~25°C) on 
benchtop (no aeration) in LB containing kanamycin [25 μg/mL] for 110 hours then 
subcultured in LB broth in the absence of antibiotics.  The first step of 
subculturing consisted of diluting overnight cultures (1:20) in LB broth and 
growing for 2 hours with aeration (250 rpm) for Hfq+ and RpoS-).  For Hfq- and 
DksA-(cells), the first step consisted of diluting overnight cultures (1:20) in LB 
broth and growing for 4 hours with aeration (250 rpm).  After the first step of 
subculturing, Hfq+ and RpoS- cell cultures were moved to a gentle shaker (50 
rpm) at 37°C for an additional 2 hours.  Cell cultures containing Hfq- and DksA-
donor cells were grown with gentle shaking for 50 rpm for 4 additional hours.  The 
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extended growth time for the mutant strains allowed the slow growing Hfq- and 
DksA- donor cells to reach a similar cell density as the NK5830F’ cells.  Recipient 
HB101 cells were grown in LB broth at 250 rpm at 37°C to reach an OD600 of 0.5.  
Recipient and donor cells were gently mixed at a ratio of (2.5 mL : 1 mL) 
respectively and grown at 50 rpm at 37°C for an additional hour.  Cell mixtures 
were vortexed for 30 seconds.  One mL of cell mixture was removed, centrifuged 
(4000 rcm for 4 minutes) and resuspended in 1 mL of 0.85% saline.  To 
determine the number of exconjugates (recipient cells that received the F-
plasmid), cell mixtures were plated on M9 plates containing glucose [0.2%], 
leucine [40 μg/mL], thiamine [1 μg/mL] and streptomycin [150 μg/mL].  To 
determine the number of transposition events (cells that received an F-plasmid 
that also contained a marked IS element), cell mixtures were plated on M9 plates 
containing glucose [0.2%], leucine [40 μg/mL], thiamine [1μg/mL] streptomycin 
[150 μg/mL], and kanamycin [25 μg/mL].  The transposition frequency was 
determined by the following equation: 
                         
                          
                 
 
 For the sRNA overexpression mating out assays, the same procedure 
outlined above was followed with the following exceptions.  NK5830 F’ and its 
Hfq- isogenic mutant DBH16 were co-transformed with pDH502 as an IS10-Kan 
source and one of the sRNA expression plasmids (pDH694-696) for DsrA, RhyB 
or MicC.  Transformants were plated on LB-selective media containing 
tetracycline [10 μg/mL] and kanamycin [25 μg/mL] either in the presence or 
absence of 1mM IPTG for induction.  Selection and induction conditions 
 29 
remained the same for overnight cultures.  The rest of the procedure remained 
the same as outlined above.  For GlmZ overexpression, the same procedure was 
followed with the exceptions outlined below.  The source of IS10Kan was 
pDH602 (to avoid plasmid incompatibilities).  IPTG was used at a concentration 
of 100 μM and the antibiotics used were ampicillin [50 μg/mL] and kanamycin [25 
μg/mL].  Cells were checked after the overnight incubation (by using the Sigma-
Aldrich Mini-prep kit) to ensure cells maintained both plasmids. 
 
Table 2.3 Oligos used in this thesis. 
Oligo Use Sequence 
BM1A Forward primer for IS1413  GAGCTAAAGTCGGAAGT
GGTGTACGGGGAGTTGA
GGC 
BM2A Reverse primer for IS1413 (Full Length) GAGCTAACGTCAAGAGTG
GTGTATGAGCAATTTGA 
BM3A Forward primer for IS1413 SELEX site 
mutation B in the LacZ translational 
fusion) 
CGTAGCTAGCAGCTGATT
GTCGAAGTCGGAAGCCA
GCGAACACCAA 
BM4A Forward primer for IS1413 for mutation 
C in the SELEX Site for LacZ-
Translational fusions 
CGTAGCTAGCAGCTGATT
GTCGAAGTCGGAAGCCA
GTAAACTACAA 
BM5A Reverse primer for LacZ gene for 
introduction into pBad24 vector 
CGATGCATGCACTGTTAT
TTTTGACACCAGACC 
BM6A Reverse primer to complete the IS1413 
sequence in the Xho I mutation 
TCAAATTGCTCATACACC
ACTCTTGACGTTAGCTC 
BM7A Reverse primer for introduction of a Xho 
I site into IS1413 
AGCAATTTGACGGCGCTC
GAGTTCAAGC 
BM8A Forward primer #1 for IS10 3’ RLM-
RACE nested PCR 
GAGCCATGGGTTCTAGCA
ACTAACTTACC 
BM9A Forward primer #2 for IS10 3’ RLM-
RACE nested PCR 
TACGCCATAGCCGAACGA
GCAGC 
BM10A Forward primer for introduction of the 
BM1 mutation in IS10 
TTGCGGCATTCTGGCTAT
ACAATAACACGGGAAGAC
TTACTCG 
BM11A Reverse primer for introduction of the 
BM1 mutation in IS10 
CGAGTAAGTCTTCCCGTG
TTATTGTATAGCCAGAAT
GCCGCAA 
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BM12A Forward primer for introduction of the 
BM2 mutation in IS10 
TTGCGGCATTCTGGCTAC
ACGATAACGAGGGAAGA
CTTACT 
BM13A Reverse primer for introduction of the 
BM2 mutation in IS10 
AGTAAGTCTTCCCTCGTT
ATCGTGTAGCCAGAATGC
CGCAA 
BM14A Forward primer for  3’ RNA-IN (includes 
a T7 RNA Polymerase promoter) 
TAATACGACTCACTATAG
GGCTGGCTACACAATAAC
AAGGGAAG  
BM15A Reverse primer for  3’ RNA-IN (includes 
a T7 RNA Polymerase promoter) 
CTGAGAGATCCCCTCATA
ATTTCCCCA 
BM16A Forward primer for  3’ RNA-IN BM1 
(includes a T7 RNA Polymerase 
promoter) 
TAATACGACTCACTATAG
GGCTGGCTATACAATAAC
ACGGGAAG 
BM17A Reverse primer for  3’ RNA-IN BM1 
(includes a T7 RNA Polymerase 
promoter) 
TAATACGACTCACTATAG
GGCTGGCTACACGATAAC
GAGGGAAG  
BM18A Reverse primer to introduce a stop 
codon in the IS10-LacZ translational 
fusions, for subsequent cloning to 
make the new IS10-Kan construct 
 
 
TCATAATTTCCCCAAAGC
GTAACC 
BM19A Reverse primer (1) for the RNA-Adapter 
in 3’ RLM RACE nested pcr 
(DE-193) 
TTTCATCAAAGCCAGCAA
ACGC 
BM20A Reverse primer (2) for the RNA Adapter 
in 3’ RLM RACE nested PCR 
RNA Adapter 
(DE-194) 
CAAACGCAGTGTTCATTC
ATCGCC 
BM21A RNA-Adaptor for 3’ RACE GCUGAUGGCGAUGAAUG
AACACUGCGUUUGCUGG
CUUUGAUGAAA 
BM22A Forward primer for kanamycin 
resistance gene 
GCTCTAGACTGAGAGATC
CCTCATAATTTCCCCTCA
GCAAAAGTACGATTTATT
CAAC 
BM23A Reverse primer for kanamycin 
resistance gene 
GGACTAGTGCCAGTGTTA
CAACCAATTAACCAATTC
TGA 
BM24A Forward primer for kanamycin gene 
(with a Sal I cut site introduced)  
ACGCGTCGACTCAGCAAA
AGTACGATTTATTCAAC 
BM25A Reverse primer for kanamycin gene 
(with a Sal I cut site introduced) 
ACGCGTCGACGCCAGTG
TTACAACCAATTAACCAAT
TCTGA 
BM26A Forward primer for IS10 NNCAGCTGATGAATCCCC
TAATGATTTTGG 
BM27A Reverse primer for IS10 GGACTAGTTCATAATTTC
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CCCAAAGCGTAAC 
BM28A Forward primer for rrsb (16S rRNA) RT-
PCR 
CGTGTTGTGAATGTTGGG
TTAAGT 
BM29A Reverse primer for rrsb (16S rRNA) RT-
PCR 
AACCCACTCCCATGGTGT
GACGGGC 
BM30A Forward primer for glmZ RT-PCR GTAGATGCTCATTCCATC
TCTTATGTTC 
BM31A Forward primer for glmZ (includes a T7 
RNA Polymerase promoter) 
TAATACGACTCACTATAG
GGTAGATGCTCATTCC 
BM32A Reverse primer for glmZ AAAACAGGTCTGTATGAC
AACAAGTGG 
BM33A Forward primer for rdlC (includes a T7 
RNA Polymerase promoter) 
TAATACGACTCACTATAG
GGTCTGGTTTCAAGATTA
GCC  
BM34A Reverse primer for rdlC AGAAAACCCCCGCACGTT
G 
BM35A Forward primer for sroG (includes a T7 
RNA Polymerase promoter) 
TAATACGACTCACTATAG
GGCTTATTCTCAGGGCG 
BM36A Reverse primer for sroG CGTTACTCTCTCCCATCC
GGAC 
BM37A Forward primer for micC RT-PCR GTTATATGCCTTTATTGTC
ACAG 
BM38A Reverse primer for micC-RT-PCR AAAGCCCGGACGACTGTT
CG 
BM39A Forward primer for pLlacO1 rhyB NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAAACACA
TCAGATTTCCTG 
BM40A Reverse primer for pLlacO1 ryhB  NNGAACCGGTTCNNAAAA
GCCAGCACCCGGCT 
BM41A Forward primer for pLlacO1 micC NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAGTTATA
TGCCTTTATTGTC 
BM42A Reverse primer for pLlacO1 micC NNGAACCGGTTCNNAAAA
AAAGCCCGGACGAC 
BM43A Forward primer for pLlacO1 dsrA NNCCATGGNNATAAATGT
GAGCGGATAACATTGACA
TTGTGAGCGGATAACAAG
ATACTGAGCACAGCGATC
AGGAAGACCCTC 
BM44A Reverse primer for pLlacO1 dsrA NNGAACCGGTTCNNAAAT
CCCGACCCTGAGGG 
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2.4 Finding putative Hfq binding sites in IS Elements: 
 The following families were searched for on the IS Finder database 
(http://www-is.biotoul.fr/): IS1, IS3, IS4, IS5, IS6, IS21, IS30, IS66, IS91, IS110, 
IS200, IS605, IS256, IS481, IS630, IS982, IS1380, ISAs1, ISL3, Tn3, IS1595, 
IS1182, IS1634, ISH3, and IS701.  The search results were given as a table and 
copied and pasted into Microsoft Excel.  The URLs of each specific IS Element 
were extracted to create lists of the URLs of all elements within a family.  
WebSphinx Webcrawler (http://www.cs.cmu.edu/~rcm/websphinx/) was then 
used to compile all of the URLs within each family into one concatenated 
webpage saved as a text file.  A Microsoft Word 2010 Macro was then used to 
extract the following fields from the compiled text files: Family, Element, Hosts, 
Transposition (Y or ND) IS_SEQ Comments and References, and put into a tab 
delimitated excel file (see Script A1.1 in Appendix I) and more details.  This 
Microsoft Excel file was then searched using the SELEX site AAYAAYAA, 
yielding the above results.  In the database there were 3478 active links; 226 of 
the IS-Elements were tested for transposition (Y) = 6.50% of submitted 
sequences being actually transposing elements. 
2.5 β-Galactosidase assays: 
 E. coli cells (NK5830F’ or its isogenic hfq- derivative DBH16) were 
electroporated with transposase-LacZ translational fusions containing either an 
arabinose inducible IS1413 transposase gene portion (pDH757, pDH760 or 
pDH794) or an IS10 transposase gene portion (pDH662,664,668,669,703 or 
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704).  Transformants were grown overnight at 37°C on LB agar plates containing 
ampicillin (50 μg/mL).  Individual colonies were used to inoculate LB broth with 
ampicillin [50 μg/mL] and grown overnight at 37°C with aeration (250 rpm).  
Arabinose inducible constructs were grown either in the presence of arabinose 
[0.2%] or glucose [0.2%].  Overnight cultures were subcultured by diluting 
cultures 1:50 in LB broth in the absence of antibiotic and grown for 2 hours (for 
hfq+ ) or 4 hours (for hfq-) at 37°C.  Cultures were then placed on ice for 20 
minutes.  One mL of subculture was centrifuged (4000 rcm for 4 minutes), 
aspirated, and resuspended in MinA broth.  The turbidity of the cultures (OD600) 
was recorded on a spectrophotometer (Montreal Biotech NanoPhotometer).  Two 
hundred and fifty μL of resuspended cells were resuspended in 250 μL of LacZ 
Buffer permeablization buffer (60 mM Na2HPO4, 34 mM NH2PO4●H2O, 2.5 mM 
KCl and 50 μM MgSO4●7H2O, 1% SDS, 0.3% β-mercaptoethanol).  Fifty μL of 
chloroform was added to each tube of permeabilized cells.  Cells were lysed at 
30°C for 5 minutes, followed by the addition of 100 μL of ortho-Nitrophenyl-β-
galactosidase [4 mg/mL in LacZ Buffer] (this is considered the start time of the 
reaction).  Samples were incubated at 30°C until they took on a yellow hue after 
which 250 μL of sodium carbonate [100 μg/mL] was added (this is considered the 
stop point of the reaction).  Samples were further incubated for 5 minutes at 
30°C, centrifuged (max speed, 5 minutes) and decanted into a cuvette.  The 
optical density was measured for each sample at wavelength 420 nm and 550 
nm.  Miller units were calculated using the following equation: 
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Where  
t = Elapsed time from start to finish 
v= volume of cells used 
 
2.6 Hfq protein purification: 
 Hfq protein was purified as described in 18. 
 
2.7 In vitro transcription and RNA labeling: 
 DNA templates for in vitro transcription were made via PCR.  Wild type, 
BM1 mutant and BM2 mutant RNA-IN run off transcription templates (bp 1222-
1329) were prepared using a T7 RNA polymerase (RNAP) promoter containing 
forward primer BM14A, BM16A or BM17A respectively.  A common reverse 
primer BM15A, was used for each transcript.  The sRNAs GlmZ, RdlC, and SroG 
run off transcription templates were prepared using the primer pairs 
BM31A/BM32A, BM33A/BM34A, and BM35A/BM36A.  The forward primers 
BM31A, BM33A and BM35A all contain T7RNAP promoters.  The resulting 
amplicons were gel purified using the QIAEX II Gel Extraction kit and protocol 
(Qiagen). 
 Run off in vitro transcription reactions consisted of 100 ng of linear DNA 
template, rNTP mix {NEB) ( rATP [0.5 mM], rCTP [0.5mM], rGTP [0.5 mM]), 
2.5μL of α32P- UTP [3000Ci/mMol] (PerkinElmer) 20 units of RNasin (Promega), 
50 units of T7 RNA polymerase (NEB), 1X BSA (NEB), 16 μM MgCl2, 10 mM 
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DTT, inorganic pyrophosphatase [0.25U] (NEB) and T7 RNA polymerase buffer 
[1x] (NEB).  For in vitro transcription of unlabeled RNA, α32P- UTP was replaced 
with 0.5 mM rUTP.  The reaction was incubated at 37°C for 30 minutes.  Two μL 
of Turbo DNase (Invitrogen) was added to the reaction mixture and incubated for 
another 30 minutes.  The reaction mixtures were run through a BioSpin 30 
column (BioRad).  An equal volume of stop dye (10 mM EDTA [pH 7.5]; 97.5% 
formamide (v/v); 3 mg (w/v) xylene cyanol and bromophenol blue) was added to 
reaction mixtures.  The reaction mixtures were then loaded on a 10% denaturing 
(3M urea) polyacrylamide gel and ran at 21V/cm until the bromophenol blue dye 
reached the bottom of the gel.  RNA bands were cut out of the gel and eluted 
overnight at 42°C in elution buffer (0.25M ammonium acetate [pH 5.8], 1 mM 
EDTA [pH 8], 0.1% SDS ).  The RNA was ethanol precipitated in 200 μL aliquots 
by adding 8 μL of DEPC treated NaCl [5M], 1 μL of glycogen (20 mg/mL), 4 μL 
EDTA (100 μM, pH 8.0), and 700 μL of 100% ethanol.  Samples were incubated 
at -72°C for 30 minutes, centrifuged at maximum speed for 30 minutes at 4°C, 
washed twice with 70% ethanol and dried until no liquid remained (~ 5-10 
minutes).  RNA was resuspended in Hfq buffer (50 mM Tris [ph 7.5]; 1 mM 
EDTA; 250 mM ammonium chloride; 10% glycerol)) and quantified using a 
spectrophotometer (Montreal Biotech NanoPhotometer).   
2.8 Electrophoretic mobility shift assays:  
 RNA (32P labeled or unlabelled) was thawed on ice, heated at 95°C for 2 
minutes, and then immediately put back on ice.  Hfq protein was diluted in Hfq 
buffer to appropriate concentrations.  RNA concentrations are indicated in the 
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figure legends of the appropriate experiments.  When two species of RNA were 
being looked at simultaneously (pairing experiments), the two RNA species were 
mixed together and incubated at 37°C for 15 minutes.  For competition 
experiments, Hfq was preincubated with the competitor RNA (dsrA or polyA16) for 
10 minutes at room temperature followed by the addition of RNA-IN for an 
additional 10 minute incubation at room temperature.  For EMSAs looking at only 
one RNA species, Hfq the RNA were incubated for 10 minutes at room 
temperature together in 10 μL.  Binding reaction mixes had load mix added (20 
mM Tris-HCl pH 7.5, 10 mM DTT, 100 mM KCl, 30% glycerol; 0.05% w/v 
bromophenol blue) and were loaded onto a 6% native polyacrylamide gel.  Gels 
were run at 21V/cm until the bromophenol blue ran to the bottom.  The gel was 
then dried, and analyzed using a Phosphoimager (Storm 860 Scanner) and 
ImageQuant software (GE Life Sciences). 
 
2.9 RNA-sRNA basepairing predictions: 
 The sRNA map database 69 was downloaded from 
(http://srnamap.mbc.nctu.edu.tw/download.php).  The sRNA sequences were 
then merged into one file using MS-DOS’s copy function.  The resulting text file 
was used as the source of RNA sequences and was pasted into the ncRNA field 
of IntaRNA; IS10 transposase DNA sequence was then pasted into the mRNA 
field of IntaRNA.  The results table from INTARNA was copied into MS-Excel 
2010, and sorted according to the stability of the resulting paired species 
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between the mRNA and sRNA.  The parameters set for IntaRNA were: 37°C and 
a minimum seed region of 7 basepairs. 
2.10 3’ RNA ligase-mediated rapid amplification of cDNA ends (3’ RLM-
RACE): 
 Three prime RLM-RACE was conducted as described in 70.  NK5830 F’ 
cells containing the Tn10 containing plasmid pBE10 was grown to exponential 
phase (OD600 = 0.6) in LB broth containing tetracycline [10 μg/mL].  Cells were 
grown at 37°C with aeration.  Total cellular RNA of the Tn10 expressing NK5830 
F’ cells was extracted using the RNEasy kit (Qiagen) according to manufacturer’s 
protocol.  The RNA ligation reaction mixture contained: 2 μg of total cellular 
RNA,T4 RNA Ligase Buffer (1X, NEB), DMSO (10% v/v), 20 U of RNAsin 
(Promega), RNA adapter BM21A [1.5 ng/μL], 20 units of T4 RNA ligase (NEB), 
and DEPC H2O to bring the reaction mixture volume to 50 μL.  The RNA ligation 
mixture was incubated for 1 hour at 37°C and then cleaned up using the RNEasy 
kit (Qiagen) eluted in 30 μL of RNase free H2O.  The RNA was then subjected to 
reverse transcription PCR.  Five μL of each sample containing the ligated RNA 
adapter was mixed with2 μL of BM19A [20 μM] and 4.5 μL of nuclease free H2O.  
The reactions were heated to 75°C for 5 minutes and then immediately cooled on 
ice.  To the reaction mix, 1 μL of Moloney Murine Leukemia Virus Reverse 
Transcriptase (M-MuLV RT) [200000 units/mL] (NEB), 5 μL of dNTP mix [10 mM], 
2 μL of M-MuLV RT Buffer [10x] (NEB) and 0.5 μL of RNasin inhibitor was added.  
The reverse transcription reaction was incubated at 25°C for 5 minutes, 37°C for 
1 hour, and 72°C for 10 minutes.  Reaction mixtures were put through a PCR 
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clean up column (Qiagen) and eluted in 30 μL of nuclease free H2O.  The 
resulting cDNA mixture underwent a nested PCR reaction.  For the first reaction 5 
μL of cDNA was mixed with 1.25 μL of primers BM8A/BM19A [20 μM each], 5 μL 
H2O and 12.5 μL of GoTaq Master Mix (Promega) [2X].  PCR cycling parameters 
were as follows: 98°C for 2 minutes for an initial denaturing, followed by 10 cycles 
of 98°C for 30 seconds, 64.5°C for 40 seconds, and 72°C for 2 minutes.  The 
PCR mixture (mix 1) was diluted with 180 μL of ddH2O.  This diluted mix 1 was 
then used for a second round of amplification consisting of 5 μL of diluted mix, 
1.25 μL of primers BM9A/BM20A [20 μM each], 5 μL of H2O and 12.5 μL of 
GoTaq Master Mix (Promega).  PCR cycling parameters were as follows: 98°C 
for 2 minutes for an initial denaturing, followed by 30 cycles of 98°C for 30 
seconds, 68°C for 40 seconds, and 72°C for 2 minutes.  A final extension step 
was performed at 72°C for 5 minutes.  The PCR amplicons were gel purified 
using the QIAEX II Gel Extraction Kit (Qiagen) according to the manufacturer’s 
protocol.  Gel extracted amplicons were cloned into the T-vector pGEM-T-EASY 
(Promega) and used for electroporation of DH5α electrocompetent E.coli cells.  
Plasmids were extracted from individual clones using the GenElute™ Plasmid 
Miniprep Kit (Sigma-Aldrich) and sent for sequencing using primer BM9A. 
2.11 Western blots: 
 For Hfq semi-quantification in NK5830 F’ cells and its rpoS- isogenic 
derivative in the mating out assays, individual colonies were grown in LB broth 
containing kanamycin [25 μg/mL] in conditions identical to the mating out assay.  
Three mL of cell cultures were centrifuged (1 min, maximum speed) and 
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resuspended in 20 μL of 1X Laemmli load dye and boiled for 5 minutes.  Cell 
lysate was briefly centrifuged to collect lipids to the bottom of the tube.  Ten μL of 
supernatant was loaded on a 12% Tricine SDS Polyacrylamide gel.  Samples 
were run at 100V on the Mini-Protean II system (BIO-RAD) with 1X tricine buffer 
(0.1 M Tris, 0.1 M tricine and 0.1% SDS) until the samples passed through the 
stacking gel.  The voltage was then increased to 150V and run until the 
bromophenol blue dye front reached the bottom of the gel.  Proteins were 
transferred to a PVDF membrane (45 mA for 40 minutes).  Hfq was detected 
using a rabbit polyclonal Hfq antibody (diluted 1:100,000 in 2.5% powdered non-
fat milk (Nelson) in TBST (2 mM Tris pH7.5, 0.5% Tween-20, 15 mM NaCl)) and 
a Goat Anti-Rabbit IgG (H+L), conjugated to horseradish peroxidase (1:4000 
dilution in 2.5% powdered non-fat milk (Nelson) in TBST) (Pierce).  PVDF 
membranes were imaged using the Storm 860 Scanner.  PVDF membranes were 
then stained by Coomassie stain, and a picture was obtained for sample 
normalization on an Alpha Imager.  Western blot and coomassie images were 
analyzed for band intensity using ImageJ software (NIH). 
2.12 Verification of sRNA induction: 
Plasmids containing IPTG inducible sRNAs (pDH694-696, pDH673), were 
verified to induce via IPTG by extracting RNA from NK5830F’ E. coli  in the 
presence or absence of IPTG RNA was extracted from exponentially growing 
NK5830F’ cells (OD600=0.6) and isolated using the hot phenol extraction method 
as described in 71. RNA was quantified using a spectrophotometer and RNA 
purity was ensured by ensuring an OD260/280 ratio of ≥1.8 and an 
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OD260/OD230 ratio ≥1.5. RNA samples were also checked for integrity by 
resolving 5S, 16S and 23S ribosomal RNA molecules on a 1% agarose gel. 
Reverse transcription PCR was performed using M-MuLV reverse transcriptase 
(NEB), Taq DNA polymerase (Promega), 1 μg of cellular RNA and primers 
BM37A/BM38A [2 μM each] for MicC and BM30A/BM32A [2 μM each] for GlmZ. 
The primer pairs for 16S rRNA were BM28A/BM29A. PCR was performed for 
MicC using the following parameters: 98°C, 30 s; 55°C, 45 s; 72°C, 60 s and 
cycled 19 times. The 16S rRNA PCR parameters are the same as above except 
that the annealing temperature was 62°C and cycled 7 times. The GlmZ PCR 
parameters were the same as above except the annealing temperature 60°C and 
cycled 11 times. To ensure PCR was within linear range, 2 more subsequent 
PCR cycles were done on each transcript (1 at a time) and the resulting amplicon 
approximately doubled in intensity. 
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Chapter 3 - Results 
3.1 How common is the Hfq mediated repression of transposase expression 
in IS Elements? 
Hfq is negative regulator of transposase gene expression in both IS10 and 
IS50 elements 18,51.  In this work I asked the question of how common is it for a 
transposase to be regulated by Hfq? To start addressing this question, I had to 
devise a method of how to systematically identify known IS Elements for potential 
Hfq regulation.  One method of doing this would be to individually clone random 
IS Elements into an expression vector and look at either transposase expression 
levels or transposition frequencies in the presence or absence of Hfq.  One issue 
with this method is the possibility that it may be difficult to express IS Elements 
from certain organisms in E.coli. To overcome this expression issue, a collection 
of different bacterial species with the appropriate hfq gene disruptions would be 
required.  The other issue is that some of these species may require growth 
media and conditions that cannot be achieved with the equipment available in the 
laboratory.  To prevent these possible technical difficulties, I chose to search the 
IS Finder database 72 for transposase genes that contain putative Hfq binding 
sites to give a list of candidates that may be Hfq regulated.  This list is a starting 
point to determine which elements to then test for transposition activity in the 
presence and absence of Hfq.  A possible caveat of this approach is that it is 
using Hfq binding motifs determined for E. coli Hfq. The possibility remains that 
other organisms' Hfq may have different binding preferences.  Studies have been 
done on how effective interspecies Hfq can complement Hfq deletions in E.coli.  
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One can presume that if a xenotropic hfq gene can complement an hfq deletion 
mutant, the two proteins are acting in similar manner.  A study by Schilling et al, 
shows that one can complement an E.coli strain MC4100 AM111 hfq deletion 
with the hfq gene from Acinetobacter baylyi to relieve the slow growth phenotype 
in LB media.  In the Acinetobacter case, the Hfq protein is larger than the E.coli 
homologue (174 amino acids verses 102 amino acids respectively) with an 
elongated glycine rich C-terminus73, yet still can complement the growth defects 
of an E. coli Hfq deletion.  Another study by Sonnleitner et al. involving 
Pseudomonas aeruginosa rpoS gene activation (which is an Hfq dependent 
process), showed that Pseudomas' Hfq can functionally complement rpoS gene 
activation defects in hfq disruption strains of E.coli. RpoS gene activation and 
rpoS independent pathways that are affected by Hfq deletions were all restored 
when expressing the Pseudomonas Hfq homolog in E.coli  74.  This database 
searching strategy is a little more simplified than the successful approaches used 
for sRNA discovery that consist often of searching intergenic regions of bacterial 
genomes for orphan promoters.  For example, a study by Chen et al. searched 
E.coli intergenic regions for genes between a σ70 promoter and a Rho-
independent terminator.  These searches resulted in 227 candidates to be sRNA 
genes 75.   
The goal of my bioinformatics approach was to identify potential Hfq 
binding sites in IS Elements which may imply binding to and regulation of the 
element.  To do this, all IS Elements submitted to the IS Finder database 72 were 
compiled into a series of files which were then searched for the two Hfq binding 
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sequences AAYAAYAA and AYAATAA.  These consensus sequences were 
identified by Lorenz et al in a genomic SELEX screen for Hfq binding RNAs 44, 
and are consistent with the ARNx motif of Hfq previously identified by Link et al to 
bind the distal face 41.  It is important to note that Hfq binding is sequence and 
structurally dependent. Hfq often binds motifs consisting of U rich regions 
upstream of a single or double hairpin 76.  The IS Finder database contained 
3478 active IS entries (as of February 2011).  Of these 3478 entries only 226 of 
the entries were actually tested to be active IS Elements.  Both AAYAAYAA and 
AYAATAA motifs were found at a variety of positions within the IS Elements' 
transposase transcripts.  For the AAYAAYAA motif, 3 of the motifs are in the 5' 
region of the transcripts, 7 of the motifs are in the middle region of the transcripts, 
and 5 of the motifs are in the 3' region of the transcripts (Table 3.1) for a total of 
14 identified sequences.  The family distribution of AAYAAYAA containing IS 
Element transposases' include IS3, IS4, IS21, IS30, IS256 and lSl3.  For the 
AYAATAA motif, 6 of the motifs are in the 5' region of the transcripts, 6 of the 
motifs are in the middle region of the transcripts, and 6 of the motifs are in the 3' 
region of the transcripts (Table 3.2) for a total of 18 identified sequences.  The 
family distribution of AYAATAA containing IS element transposases include IS3, 
IS4, IS5, IS21, IS30, IS110, IS630, and IS1380.  Since, IS Elements have 
different DNA base compositions, I also calculated what the probability of finding 
the number of SELEX sites in each element based on their length and DNA base 
composition.  The binomial cumulative distribution function of Microsoft Excel 
2010 was used to calculate the probability of finding exactly the number of 
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putative Hfq binding sites that were reported in each element (See Appendix I for 
sample calculations.) 
Using this bioinformatics approach, I have identified 32 IS Element 
transposase genes that may be under the regulation of Hfq using putative Hfq 
binding sites.  This provides a list of IS Element transposase genes that are 
candidates for further characterization of their regulatory sequences and 
interactions with Hfq. 
3.2 Hfq regulation of IS1413: 
To verify the effectiveness of my bioinformatics search to predict Hfq 
regulation in IS Elements the effect of Hfq on IS1413 transposase expression 
was tested.  Our fourth year honours student Morgan Black used my 
bioinformatics analysis as the basis to perform electrophoretic mobility assays 
(EMSA) to demonstrate that both E.coli and Burkholderia Hfq bind IS1413's 
transposase transcript in vitro.  She also showed using an IS1413 transposase-
LacZ translational fusion, that the expression of the IS1413 transposase is 17.8 
fold higher in hfq-- E.coli cells than in E.coli cells encoding a functional hfq gene. 
In this section of the thesis I address 2 questions arising from Morgan's initial 
observations: 
1. Is the Hfq repression of IS1413 transposase expression dependent on the 
AAYAAYAA sequence found in the 5' UTR? 
2. Does Hfq repress IS1413 transposition in E.coli 
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Table 3.1 Elements in the IS Finder database containing the predicted Hfq binding sequence AAYAAYAA.  
IS Elements were merged into one file from the IS Finder Database (http://www-is.biotoul.fr/) utilizing the 
WebCrawler Web Sphinx 77.  Relevant fields were extracted utilizing the find and replace functions in Microsoft 
Word 2010, and finally the location of the SELEX defined Hfq binding site was determined.  This information is 
current as of February 2011.  The P-Value represents the probability that one would find exactly the number of 
binding sites found for the given element (the probability mass function) and was calculated using Microsoft Excel 
2010.  A probability of 1 would represent a SELEX site that is probably unimportant; as it appears the number of 
times one would expect it to. A probability of 0 would represent a SELEX site that you would expect to see either 
much more or less than one observed.  See Appendix I for P-value calculations. SELEX Locations are denoted in 
the far right column preceded by the number of SELEX sites found in the IS Element’s transposase mRNA 
sequence. 
 
IS Family IS Element Length 
bp 
GC 
Content 
P-Value Organism SELEX Location 
IS3 IS1223 1494 32% 3.23x10
-1
 Lactobacillus johnsonii (1) Middle 
IS3 IS1550 1408 24% 6.81x10
-2
 Mycoplasma fermentans (3) Middle 
IS3 IS199 1220 43% 1.38x10
-1
 Streptococcus mutans (1) 5’ end UTR 
IS3 ISMmy2 1374 28% 3.54x10
-1
 Mycoplasma mycoides (1) 3’ end 
IS4 IS10R 1329 44% 1.36x10
-1
 Salmonella typhimurium (1) 3’ end 
IS4 IS186A 1341 51% 6.71x10
-2
 Escherichia coli (1) 3’ end 
IS4 IS186B 1338 51% 6.70x10
-2
 Escherichia coli (1) 3’ end 
IS21 IS21 2131 52% 9.17x10
-2
 Pseudomonas aeruginosa (1) Middle 
IS21 IS232A 2184 34% 2.86x10
-2
 Bacillus thuringiensis (1) Middle 
(2) 5’ end of ORF2 
IS21 ISEc12 2484 48% 1.58x10
-1
 Escherichia coli (1) Middle 
IS30 ISCg2 1636 53% 6.40x10
-2
 Corynebacterium glutamicum (1) Middle 
IS256 IS1413 1428 60% 2.22x10
-2
 Burkholderia phenoltripix (1) 5’ UTR 
IS256 IS905A 1313 38% 2.17x10
-1
 Lactococcus lactis (1) Middle 
IsL3 IS1181 1513 32% 9.45x10
-2
 Staphlococcus aureus (2) 3’ end 
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Table 3.2 Elements in the IS Finder database containing the predicted Hfq binding sequence AYAATAA.  IS 
Elements were merged into one file from the IS Finder Database (http://www-is.biotoul.fr/) utilizing the webcrawler 
Web Sphinx 77.  Relevant fields were extracted utilizing the find and replace functions in Microsoft Word 2010, and 
finally the location of the SELEX defined Hfq binding site was determined.  This information is current as of 
February 2011.  The P-Value represents the probability that one would find exactly the number of binding sites 
found for the given element (the probability mass function) and was calculated using Microsoft Excel 2010. A 
probability of 1 would represent a SELEX site that is probably unimportant; as it appears the number of times one 
would expect it to. A probability of 0 would represent a SELEX site that you would expect to see either much more 
or less than one observed.  See Appendix I for P-value calculations. SELEX Locations are denoted in the far right 
column preceded by the number of SELEX sites found in the IS Element’s transposase mRNA sequence. 
IS Family IS Element Length (bp) GC 
Content 
P-Value Organism SELEX Location 
IS3 IS1138 1288 23% 2.59E-01 Mycoplasma pulmonis (1) 3’ end 
IS3 IS1520 1302 38% 3.24E-01 Lactobacillus sakei (1) 5’ UTR 
IS3 IS1550 1408 24% 1.00E-01 Mycoplasma fermentans (3) Middle 
(1) 3’ end 
IS3 ISMmy2 1374 28% 3.36E-01 Mycoplasma mycoides (1) 3’ end 
IS4 IS10R 1329 44% 2.32E-01 Salmonella typhimurium (1) 3’ end 
IS4 IS4Bsu1 1406 40% 3.06E-01 Bacillus subtilis (1) 5’ UTR 
IS4 ISBth4 2024 35% 3.62E-01 Bacillus thuringiensis (1) 5’ UTR 
IS5 IS903B 1057 53% 8.09E-02 Escherichia coli (1) 5’ end 
IS5 ISC1058 1058 43% 2.13E-01 Sulfolobus solfataricus (1) Middle 
IS21 IS232A 2184 34% 3.45E-01 Bacillus thuringiensis (1) Middle of ORF 1 
IS30 ISAs2 1084 59% 3.84E-02 Aeromonas salmonicida (1) 5’ UTR 
IS30 ISCg2 1636 53% 1.20E-01 Corynebacterium 
glutamicum 
(1) Middle 
IS110 IS492 1202 42% 2.49E-01 Pseudomonas atlantica (1) 5’ UTR 
IS630 IS630 1153 52% 9.82E-02 Shigella sonnei (1) 3’ end 
IS1380 IS942 1598 40% 3.25E-01 Bacteroides fragilis 
TAL3636 
(1) 3’ UTR 
IS1380 ISEc9 1656 33% 3.63E-1 Escherichia coli (1) Middle 
IsH3 ISC1439A 1439 39.00% 3.24E-01 Sulfolobus solfataricus PH1 (1) 3’ end 
IsL3 IS1181 1513 32.00% 2.11E-01 Staphylococcus aureus 
BM3121 
(1) Middle 
(1) 3’ End 
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To address the first question, two mutations were made in the SELEX site 
of IS1413's transposase gene.  Mutations were made to disrupt the SELEX site 
or secondary structure around the SELEX site.  Amino acid changes or codon 
bias was not considered in these mutations, as the SELEX site is in the 5' UTR of 
IS1413 transposase.  Mutant B contained an adenine to a guanine mutation at 
position 108 and an adenine to a cytosine mutation at position 113 (Figure 3.1 B, 
sequence B).  Mutant C contained a cytosine to thymine mutation at position 107 
and an adenine to a thymine mutation at position 112 (Figure 3.1 B, sequence 
C).  To determine the effect of IS1413 transposase's SELEX site mutations on 
Hfq regulation, transposase expression was determined in cells containing an 
intact hfq gene as well as isogenic cells containing an hfq disruption.  
Transposase expression was measured through the use of transposase-LacZ 
translational fusions.  The first 445 base pairs of IS1413 and the two mutants 
were fused to the sequence encoding the ninth codon of LacZ.  These mutants, 
as well as the wild type sequence were then put under control of an arabinose 
inducible promoter (p-Ara) to increase transcription and transposase expression 
was tested in both hfq+ and hfq- backgrounds.  For the wild type construct, there 
is a 3 fold increase in expression (i.e.  β-galactosidase activity) in hfq- cells when 
comparing isogenic hfq+ and hfq- strains (Figure 3.1A).  In comparison, both 
mutant constructs gave an increase in transposase expression of around 10-fold 
in both genetic backgrounds (Figure 3.1A).  An increase of transposase 
expression in the mutant constructs was surprising, as the hypothesis predicted 
that there only should have been an increase in activity in hfq+ cells.  The overall 
increase in transposase expression may be explained by the mutations providing 
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a better ribosome binding site than the wild type sequence.  To date, the actual 
ribosome binding site of IS1413 has not been characterized, but it would likely be 
around the proximity of the SELEX site.  Another possibility is the mutations may 
increase either steady state levels of the transcript or increase the half-life of the 
transcript.  Mutant B shows a 3 fold increase in activity in the hfq- strain relative to 
the hfq+ strain (Figure 3.1A).  Mutant C shows a 1.5 fold increase in activity in 
the hfq- strain relative to the hfq+ strain.  Overall, Hfq has an effect on expression 
of IS1413, however, more mutant forms of IS1413 will have to be tested to hone 
into the sequence that Hfq is potentially binding to.  There is a possibility that 
other Hfq binding sites may exist in other regions of the IS1413 transposase 
transcript which may be the reason why mutation analysis did not abolish Hfq 
repression.  Another possibility is that the Hfq effect is actually indirect.  For 
example, Hfq is a known regulator of many genes within bacteria such as rpoS (a 
gene encoding a sigma factor often associated with stress responses) 78, and it 
could be a gene under RpoS' control that is the cause of the increased 
transposase expression in hfq- cells.  These remain possible avenues for future 
investigation. 
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Figure 3.1 β-galactosidase activity for IS1413-LacZ translational fusions. 
Translational fusions were transformed into NK5830 F’ (Hfq+) or its isogenic Hfq- 
derivative and Miller assays were performed.  This data shows the means and 
standard deviations of at least 2 independent experiments. B.  Mutations were 
made in the putative Hfq binding region (SELEX) of the IS1413 LacZ fusion under 
the control of an arabinose inducible promoter.  Construct A shows the wild type 
sequence of 1413.  Sequence B and C show the mutations made, with the 
affected nucleotide highlighted in red.  C.  A schematic of the 1413-LacZ portion 
of the β-galactosidase construct.
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To test the transposase activity of IS1413 in E. coli and to determine if the 
Hfq status affects the activity, a 'marked' IS1413 element (IS1413-Kan) was 
made by inserting a kanamycin resistance gene between the stop codon of the 
transposase and the adjacent transposase end of IS1413 (see Materials and 
Methods).  NK5830 F' cells were transformed with a plasmid containing IS1413-
Kan and a mating out assay was performed (see Materials and Methods).  
Briefly, the mating out assay involves transforming Hfq+ or Hfq- NK5830 F' E.coli 
cells (Arg-/F' laciq L8 pro) with a plasmid containing a kanamycin ‘marked’ IS1413 
element.  Transformants (donors) and HB101 (leu-, strR, F-) cells (recipients) were 
grown overnight on LB agar with kanamycin or LB agar with streptomycin 
respectively at 37°C.  Individual colonies of donors were used to inoculate LB 
broth containing kanamycin and grown overnight at 37°C with aeration (250 rpm).  
Individual recipient colonies were also picked and grown overnight at 37°C with 
aeration (250 rpm) in LB broth containing streptomycin.  Overnight cultures of 
donors and recipients were individually subcultured into selection free LB media.  
Donors were grown for 2 hours (4 hours for Hfq-) at 250 rpm at 37°C, then culture 
tubes were transferred to a slower aerator at about 50 rpm to facilitate sex piIIi 
formation for 2 hours (4 hours for Hfq-) .  Recipient cells were grown for 4 hours 
at 37°C at 250 rpm.  Recipient and donor cells were mixed together at a 5:2 ratio 
and allowed to undergo conjugation for 1 hour at 37°C at 50 rpm.  Cell mixtures 
were then vortexed, centrifuged (4000 rcm, 4 minutes), and resuspended in 
0.85% saline.  To determine the number of successful transfers through 
conjugation of the F-factor (which can be tracked by the proline gene), cells were 
plated on M9 agar plates containing glucose, streptomycin, leucine and thiamine.  
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The number of transposition events is measured by selecting for cells that have 
had the marked IS1413 element transpose onto the F-factor.  Recipients 
containing the F-factor with an IS1413 element are selected for by plating on M9 
agar plates containing glucose, streptomycin, kanamycin, leucine and thiamine.  
The transposition frequency of IS1413 is calculated by dividing the number of 
IS1413 transposition events by the total number of successful F-factor transfers.  
IS1413 has an average transposition frequency in NK5830 F’ E.coli cells of 3.7 x 
10-5 ± 7.8 x 10-5 transposition events per mL of mating mix (in the presence of 
Hfq) and 5.0 X 10-4 ± 3.8 X 10-4 transposition events per mL of mating mix (in the 
absence of Hfq) (Figure 3.2).  Thus, Hfq has a repressive effect on IS1413 
transposition, down regulating transposition events by approximately 13 fold.  
When comparing the medians of the two conditions, the trend of Hfq repression 
continues.  The median of IS1413 transposition frequency in an Hfq+ background 
being 7.85 x10-6 and the median of IS1413 transposition frequency in an Hfq- 
background being 4.85 x 10-4 resulting in a 61.7 fold increase (by median) of 
IS1413 transposition frequency in hfq- cells relative to hfq+. 
3.3 Alternative pathways of IS10 regulation by Hfq at the 3' end of the 
mRNA transcript. 
The 3' region of IS10 transposase also contains the AAYAAYAA motif as 
identified in section 3.1.  Most regulatory studies of IS10 have been focused on 
the 5' region of the transposase gene.  Hfq has already been established as a 
negative regulator of IS10 transposition 18.  This section of the thesis explores the 
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potential contribution the IS10 transposase’s 3' putative Hfq binding site has in 
Hfq repression. 
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Figure 3.2 Hfq represses IS1413 transposition.  NK5830 F’ and its Hfq- 
isogenic strain (DBH16) was transformed with a plasmid containing a kanamycin 
marked IS1413 element and grown overnight on LB medium with kanamycin [25 
μg/mL].  Cells were subcultured in LB to an OD600 of ~ 0.6 and the mating out 
procedure was followed.  Total exconjugates and total hops were calculated and 
transposition frequencies were calculated by dividing the total hops by the total 
exconjugates.  This data shows the means and standard deviations from 2 
independent experiments both with n=4.   
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One proposed mechanism of Hfq regulation on IS10, is that Hfq 
accelerates the pairing of RNA-IN and RNA-OUT (see introduction) 18.  One issue 
still remains with this proposed mechanism; when you disrupt hfq in a cell 
harbouring a single copy of IS10 (where the effect of RNA-OUT is thought to be 
negligible), Hfq still exhibits a repressive effect on IS10 transposition 18.  An 
observation from our laboratory technician, Ryan Trussler, is that transposase 
mRNA stability increases in the absence of Hfq.  The half-life of RNA-IN in the 
presence of Hfq is 0.79 minutes versus 1.1 minutes in the absence of Hfq.  These 
observations suggest that Hfq plays a role in the stability of RNA-IN.  There are at 
least two known mechanisms for how Hfq can alter the stability of RNA.  
Polyadenylation of mRNA by poly(A) polymerase I (PAP) in E. coli is stimulated 
by Hfq.  In vivo, hfq gene deletions result in shorter polyA tails on the rpoS mRNA 
transcript 79.  Polynucleotide phosphorylase (PNP), is an 3 '  5' exonuclease 
that preferentially degrades RNA with 3' polyadenylated or polyurindinylated tails 
in vitro 80.  Taken together, these observations suggest that Hfq can facilitate the 
polyadenylation of RNA transcripts resulting in polynucleotide phosphorylase 
mediated degradation 81.  Another Hfq mediated RNA degradation mechanism 
involves Hfq, sRNAs, and RNase E.  Morita et al demonstrated that RNase E co-
purifies with Hfq.  They also showed that Hfq in conjunction with an sRNA (in 
their case RhyB) is able to  target the RNase E-Hfq complex to a target mRNA 
(sodB) resulting in mRNA degradation 81.  I sought to determine if Hfq is working 
through either of these two mechanisms to promote IS10 mRNA turnover. 
Hfq binding sites on the 3' end of mRNA transcripts have been associated 
with promoting the turnover of mRNA transcripts through increased 
 54 
polyadenylation which facilitates PNP-dependent degradation.  Since this 
mechanism depends on the transcript of interest to contain a polyadenylated tail, 
I sought to define the 3' end of the IS10 transcript and establish the presence or 
absence of a polyA tail.  The transcriptional stop points of IS10 transposase have 
not previously been defined, nor has it been established if a polyA tail is present 
on the transcript.  I employed the 3' RLM-RACE technique to analyze the 3' end 
of the IS10 transposase transcript.  The source of transposase RNA for this 
experiment was a plasmid (pBE10) encoding the Tn10 transposase.  Cells 
containing pBE10 were grown to exponential phase (OD600 ~ 0.6).  Total cellular 
RNA was isolated and a RNA-adaptor (BM21A) 
(GTGATGGGCGATGAATGAACACTGCGTT) was ligated to the total cellular 
RNA molecules using T4 RNA Ligase (NEB).  RNA underwent reverse 
transcription, followed by a nested PCR reaction.  Briefly, the nested PCR 
reaction consisted of the first PCR reaction using primers BM8A and BM19A for 
10 cycles of amplification.  This first PCR reaction was diluted ten-fold in H20 and 
then 5 μL of the first round of amplification was used as a template for the second 
round of amplification.  The second round of PCR amplification used primers 
BM9A and BM20A which anneal closer together than primers BM8A and BM19A 
to reduce the chance of non-specific amplification.  The second round of PCR 
amplification was done for 30 cycles.  Specific details of the PCR reactions are 
described in the Materials and Methods section.  PCR products were run out on 
an agarose gel, gel purified, cloned into the pGEM T-easy vector (Promega) and 
transformed into DH5α.  A total of 51 clones were sent for sequencing.  Twenty-
seven of the clones had IS10R sequence, 13 of the clones had IS10L sequence 
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and 11 of the clones did not contain IS10 sequence.  Analysis of the IS10R 
sequences reveals a favoured transcription stop point in the tetD gene at bp 7718 
(relative to bp 1 of Tn10) with no signs of polyadenylation (Figure 3.3).  Analysis 
of the IS10L sequences shows that there appears to be a favoured transcription 
stop site upstream of the jemA gene at bp 2750 relative to bp 1 of Tn10 and no 
polyadenylation. 
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IS10L jem A jem B jem C tet R tet A tet C tet D IS10R 
Structure of Tn10 Transposase 
3’ RLM-RACE Alignment of IS10R Sequences 
3’ RLM-RACE Alignment of IS10L Sequences 
Figure 3.3 Three prime RLM-RACE studies show that IS10 transcripts from Tn10 
have defined stop points, with no indication of polyadenylation or Rho-
independent termination sequences.  Total RNA was isolated from NK5830F’ cells 
expressing Tn10.  Complementary DNA was synthesized using M-MLV Reverse 
Transcriptase (NEB) and IS10 mRNA was PCR amplfied.  PCR amplicons were 
cloned into pGEM T-Easy vector (Promega) and sequenced. Sequences were aligned 
and compared in MS Word 2010. 
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Overall IS10 has a defined transcriptional stop with no indications of a Rho 
independent terminator (verified by ARNold terminator predictor 82).  There is also 
no polyadenylation of the IS10 transcript.  Interestingly, there is a predicted Rho 
dependent terminator early on in the IS10 (L/R) transcript at bps 357-396 relative 
to the Tn10 DNA sequence with a predicted stability of -9 Kcal/mol (ARNold 
terminator predictor) 82, which would not be picked up with the primers used in 
this method.  With the absence of any polyadenylation on the IS10 transposase 
mRNA, it is unlikely that the reduced half-life in the presence of Hfq is due to 
neither the recruitment of PAP nor the PNPase degradation pathway.  The Hfq-
RNase E mediated degradation of IS10 transposase mRNA still remains a 
possibility and is explored in the next section. 
3.4 Does Hfq bind the 3' end of IS10? 
Absence of polyadenylation on the IS10 transposase mRNA rules out the 
PAP-PNP model of RNA degradation.  I considered the alternative model that an 
Hfq-RNase E complex might bind the 3' end of the IS10 transposase transcript 
resulting in the degradation of the mRNA.  I sought to determine if Hfq is actually 
able to bind the 3' end of the IS10 transcript.  Furthermore, since this mechanism 
of RNA degradation would be disrupted if Hfq was unable to bind the transcript, I 
looked at the effects of mutating the putative Hfq binding site.  The 3' region of 
RNA-IN (bp 1222-1329) was PCR amplified with a T7 promoter included in the 
forward primer (see Figure 3.4).  This amplicon was used as a template for ‘run 
off’ in vitro transcription using T7 RNA polymerase and rNTPs including 32P α-
CTP.   
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Figure 3.4 In vitro transcription schematic. A T7 RNA Polymerase (RNAP) 
promoter is incorporated in a forward primer for PCR amplification of the gene of 
interest. After purification of the PCR amplicon, T7 RNA Polymerase is incubated 
with rNTPs (including 32P labelled rUTP) to make the resulting radio-labelled RNA 
molecule. Unlabelled RNA molecules can be made by substituting the 32P 
labelled rUTP with an unlabelled version. 
Labelled RNA was isolated by loading on a 10% denaturing polyacrylamide and 
the prominent RNA species was cut out and eluted overnight in elution buffer.  
Eluted RNA was tested for purity by spectrophotometer and integrity on another 
10% denaturing polyacrylamide gel.  RNA preparations were quality controlled to 
ensure they gave a clean band on the denaturing gel.  Hfq binding was 
determined by EMSA.  Competition assays were used to follow up initial Hfq 
binding assays to define which face of Hfq the 3’ end of IS10 transposase mRNA 
and its mutants bind.  DsrA is a sRNA known to bind the proximal face of Hfq and 
polyA RNAs bind Hfq at the distal face 83.  By preincubating Hfq with either DsrA 
or polyA16 RNA and then adding the 3’ end of the IS10 transposase mRNA, we 
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can determine if there is any competition for Hfq binding sites.  Competition for 
Hfq binding provides evidence of which face the non-competing RNA is binding.  
For example, if one is unable to see a displacement of DsrA from Hfq, even in 
very high concentrations of RNA-IN, it is very likely that RNA-IN binds the distal 
face instead of the proximal face (where DsrA is) of Hfq.  Knowing which face of 
Hfq the 3’ end of RNA-IN binds, may help us elucidate possible roles the RNA-
Hfq complex may have in the cell.  For example, if the 3’ end of RNA-IN binds the 
proximal site of Hfq (similar to how the 5’ end binds), a potential explanation for 
its role could be that it chelates out Hfq from acting on the 5’ end of the transcript 
(see Discussion). 
The wild type sequence is predicted by Mfold 84 to form a stem loop right 
before and after the SELEX site (Figure 3.5A).  Hfq binds RNA-IN 3’ with an 
approximate KD between 6.08 and 12 nM, as suggested by over 50% of free RNA 
being bound by Hfq between Hfq concentrations of 6.08 nM and 12 nM (Figure 
3.6A +B).  The wild type sequence binds Hfq presumably on the proximal site as 
shown by it outcompeting DsrA (an sRNA known to bind the proximal sites of 
Hfq) in competition studies until DsrA is in 25 fold excess to RNA-IN (Figure 
3.7A). 
To test the specificity of the Hfq binding site on the 3' end of RNA-IN 
mutant, I looked at two different mutations.  Since I eventually wanted to look at 
the effect of Hfq binding disruption in vivo, mutations were constrained to be 
silent and have little effect on codon bias in E. coli.  I also considered potential 
positions around the SELEX site that may affect the secondary structure context 
of the site.   
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Figure 3.5 The proposed structure for each of the RNA-IN 3’ species. RNA 
structures were  predicted using Mfold 84 and their predicted stabilities are noted 
within the structures. The proposed Hfq binding site is highlighted in yellow and 
any mutations are highlighted in red A. RNA-IN 3’ (WT). B. RNA-IN 3’ (BM1) C. 
RNA-IN 3’ (BM2) 
 
The first mutant BM1 has a C1229T mutation (found just outside of the 
SELEX site) and an A1239C mutation (which disrupts the last A of the 
AAYAAYAA motif to a C).  The BM1 mutant has its modified SELEX site on a 
predicted single stranded region close to an RNA-hairpin (Figure 3.5B shown 
with changed bases highlighted in red).  The BM1 mutation resulted in an 
increase in apparent KD relative to the WT sequence, with an approximate KD 
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between 314-614 nM (Figure 3.6C).  The BM1 mutated RNA-IN likely binds the 
proximal site of Hfq due to the inability of polyA16 RNA (an RNA known to bind 
the distal site of Hfq) to outcompete the RNA-Hfq complex 2 formation at a 4.3 
fold excess.  DsrA starts to compete with RNA-IN 3' BM1 at a 4.3 fold excess, as 
shown by the loss of RNA-IN 3' BM1 Complex II (Figure 3.7B). 
The RNA-IN 3' mutant BM2 has an A1232G mutation; (mutates the first A 
of the AAYAAYAA motif to a G) and an A1238G (mutates the second last A of the 
AAYAAYAA Motif to a G).  The BM2 mutant has its modified SELEX site on a 
predicted single stranded region between 2 hairpins (shown in Figure 3.5C with 
changed bases highlighted in red), has its modified SELEX site on a single 
stranded region flanked directly by 2 hairpins and on an extend arm compared to 
the other two RNA species.  The BM2 mutation resulted in an apparent KD 
between 80-160 nM (Figure 3.6D).  RNA-IN 3' BM2 appears to bind the distal 
side of Hfq, suggested by the competition with only a 0.5 excess of polyA16 and 
no competition with DsrA at a 10 fold excess (Figure 3.7C). Hfq does specifically 
bind the 3' region of RNA-IN, and this specificity is sequence and possibly 
structurally dependent (based on mfold predictions) as shown by the modulation 
of binding affinity through the BM1 and BM2 mutations. 
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Figure 3.6 Hfq binds the last 107 nucleotides of IS10 and mutating the 
SELEX site reduces binding.  32P labelled RNA-IN 3’ and its mutants were 
mixed with varying Hfq concentrations and incubated at room temperature for 10 
minutes.  Reactions were resolved on a 6% native polyacrylamide gel.  [RNA-
IN3’] = 1.52 nM/Reaction, [BM1] = 3.45 nM/Reaction, [BM2] = 2.15 nM/Reaction.  
B. The binding curve of Hfq-3’ RNA-IN was plotted using Prism 5.0 software and 
fit to the equation Y=Bmax*X/ (Kd + X). Where Y = % of 3’ RNA-IN bound to Hfq, 
Bmax = the minimum concentration of Hfq in which 100% of 3’ RNA-IN is bound, 
X = the concentration of Hfq, and KD = the concentration of Hfq1 (in nanomoles/L) 
where 50% of 3’ RNA-IN is bound. 
 
 
 
 
 
 
[Hfq1] (nM) 
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Figure 3.7 Hfq binds the last 107 nucleotides of IS10 and binding can be 
competed using the proximal binding sRNA DsrA or the distal binding 
polyA16 RNA.  A.  
32P labelled RNA-IN 3’ [1.52 nM/reaction] and was mixed with 
varying concentrations ( 0.154 nM, 0.308 nM, 0.616 nM, 1.32 nM, 2.46 nM, 4.93 
nM, 9.86 nM, 19.7 nM, 39.4 nM) and with an Hfq concentration of 6.08 
nM/reaction and incubated at room temperature for 10 minutes.  EMSAs were 
performed on a 6% native polyacrylamide gel.  B.  32P labelled RNA-IN 3’ (BM1) 
[3.45 nM/reaction] was mixed with varying DsrA or polyA16 concentrations (3 nM, 
6 nM, 12 nM, 15 nM) and with an Hfq concentration of 1.05 μM/reaction and 
EMSAs were performed on a 6% gel.  C.  32P labelled RNA-IN 3’ (BM2) [2.15 
nM/reaction] was mixed with varying DsrA or A16 concentrations (1.3 nM, 2.5 nM, 
5 nM, 10 nM, 20 nM) and EMSAs were performed. 
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3.5 Does the BM1 mutation affect IS10 transposition frequency? 
Since the 3' mutations reduce Hfq binding and Hfq binds the 3' end of 
RNA-IN tightly, the in-vivo effects of the 3' mutations in a mating out assay were 
tested.  A new marked IS10 construct had to be made to ensure a unique 3' 
region of IS10 was present for site directed mutagenesis.  The construct that was 
available in the lab (pDH502/pDH602) had a large portion of the 3' region of IS10 
(including the SELEX site) repeated following the kanamycin gene (Figure 3.8A).  
This repeated region resulted in amplification issues when trying to do site 
directed mutagenesis to the SELEX site.  The new construct included the IS10 
sequence up to the stop codon, followed by a kanamycin gene transcribed off the 
opposite DNA strand followed by the remainder of the inside end of IS10 to allow 
for transposition (Figure 3.8A).  The IS10 portion was mutated to make the BM1 
mutation which was chosen due to its similar Hfq binding profile to the wild type 
transcript (likely binding the proximal site of Hfq, unlike the BM2 mutant which 
showed a different binding preference). 
A mating out assay was performed with NK5830 cells transformed with 
either an IS10-Kan element containing the native IS10 sequence or containing 
the BM1 mutation.  There was no difference in transposition frequencies between 
either of the constructs (Figure 3.8B).  These results suggest that the 3' SELEX 
site of IS10 transposase RNA is not a region of regulation for RNA-IN 3' in the 
environmental conditions of the mating out assay.
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Figure 3.8 The BM1 mutation does not affect transposition frequencies of a 
high copy IS10 element as measured by a mating out assay.  A.  A 
comparison of the old IS10-kan construct (pDH502) and the new one made for 
this study (pDH725).  The new construct is more modular and has less repeated 
sequence.  This makes gene manipulation more efficient.  B.  NK5830 F’ cells 
were transformed with either a wildtype IS10-kan construct or an IS10-kan with a 
mutated SELEX site construct and grown overnight on LB medium with 
kanamycin selection [25 μg/mL].  Cells were subcultured in LB to an OD600 of ~ 
0.6 and the mating out procedure was followed.  Total exconjugates and total 
hops were calculated and transposition frequencies were calculated by dividing 
the total hops by the total exconjugates.  This data is compiled from 2 
independent experiments both with n=4.  
B 
A 
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As an additional method to determine which region of the transcript Hfq 
may be acting upon, a series of IS10 truncations and mutations were explored in 
context of IS10 transposase expression using IS10-LacZ translation fusions.  The 
IS10-LacZ translational fusions are comprised of varying lengths of the IS10 gene 
sequence, fused to DNA sequence starting at the 9th codon of LacZ.  The two 3' 
mutants BM1 and BM2 were also tested in this context.  The IS10-LacZ 
translational fusions include the RNA-IN promoter as well as the entire RNA-OUT 
promoter and sequence (see Figure 3.9).  These data show a general trend of 
overall transposase expression increases as the IS10 transcript gets longer (see 
Figure 3.9).  This trend is true for all translational fusions in both the Hfq- , Hfq+ 
cells.  Structural predictions of the RNA using mFold suggest the increase in 
activity between the different transcripts is not due to occlusion of the Shine 
Dalgarno sequence nor a difference in the position of the translational start (Data 
not shown).  The longest IS10 translational fusion contains the predicted Hfq 
binding site AAYAAYAA found in the IS Finder search, and there is about a 3 fold 
increase in activity in Hfq- cells relative to wild type cells.  Both BM1 and BM2 
mutants resulted in about a 3 fold decrease in overall expression in both Hfq- and 
Hfq+ strains (Figure 3.9).  The RNA structure of the promoter region and 
translational start region in the two mutants are no different than in the wild type 
transcript according to the most stable structures using mFOLD structural 
predictions, thus is likely not the reason for the reduced activity.  Overall, it 
appears that mutating the 3' end of IS10 in the context of a transposase 
expression assay and a mating out assay does not affect transposase activity. 
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Figure 3.9 β-Galactosidase activity for IS10-LacZ translational fusions of varying lengths. Translational 
fusions were transformed into NK5830 F' (Hfq+) or its isogenic derivative DBH16 (Hfq-) and transposase 
expression assays were performed. These data are a compilation of at 2 independent experiments with each 
geometric shape representing one colony in a β-galactosidase assay. The SELEX site refers to the identified Hfq 
binding sequence AAYAAYAA from searching the ISFINDER database. Increasing amounts of IS10 sequence 
were fused to the 9th codon of a LacZ gene, as well as a mutated version of IS10 that contained 2 base changes in 
the 3’ region of the transcript. 
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3.6 Is the expression of RNA-IN regulated by an sRNA? 
Manipulation of the 3' SELEX site of RNA-IN has a minimal effect on 
transposase expression and activity regardless of the observation that Hfq binds 
RNA-IN 3’ in vitro.  The problem being looked at is that IS10 transposition is 
down regulated by Hfq up to 86 fold on a multi-copy plasmid but only up to 7 fold 
when on a single chromosomal copy 18.  RNA-OUT pairing with RNA-IN is also 
considered negligible at a single copy situation with hfq disruptions resulting in a 
2 fold decrease in transposition 11.  This led to the question: What else could Hfq 
be working in conjunction with to repress IS10 expression?  Accordingly, I tested 
an alternative mechanism for how Hfq might be regulating IS10 transposase, 
independent of the anti-sense system.  One of the major roles for Hfq in the cell 
is to bind RNA species and promote their pairing with mRNAs.  I therefore 
decided to search for E. coli sRNAs that regulate RNA-IN expression.  To 
address this possibility, a sRNA database sRNAMAP 69 was downloaded and the 
sequences searched against RNA-IN using INTARNA 85 
(http://rna.informatik.unifreiburg.de:8080/lntaRNA.jsp).  INTARNA is an online 
bioinformatics tool that allows one to predict the interactions between RNA 
molecules.  INTARNA analyzes the hybridization energy between the two 
prospective pairing RNA species as well as unfolding energies required for the 
regions of interaction of each molecule to become accessible.  This program is 
useful to find candidate RNAs that may interact with RNA of interest.  An 
interaction stability of -8 Kcal/mol cut off was used to reduce the number of 
matches, and non-E. coli sRNAs were removed from the list.  The top 20 most 
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stable sRNA-mRNA predicted interactions are reported here (See Table 3.3).  Of 
these matches an sRNA from the most stable (GlmZ), mid-stable (SroG) and 
least stable range (RdlC) were chosen to test experimentally for pairing with 5' 
region of IS10.  The predicted regions of interaction of GlmZ, SroG and RdlC are 
shown in Figure 3.10. 
 
Table 3.3 Compiled sRNAs predicted to interact with IS10  according to 
INTARNA.  Start and stop refer to the base region on the sRNA where pairing 
may occur between the sRNA and IS10.  Predictions are based on a minimum 
seed region of 7 bases for pairing. 
sRNA Kcal/mol sRNA 
Start 
sRNA 
Stop 
IS10 
Start 
IS10 
 End 
sroG  -20.232  102 130 53 85 
rseX  -18.252  11  66 709 767 
omrB  -15.919  6  46 751 790 
C0343  -15.661  4  60 541 621 
sibD  -14.587  1  24 739 761 
glmZ  -14.308  132  157 20 43 
oxyS  -14.230  48  82 107 145 
sgrS  -14.124  168  178 364 374 
ssrA  -13.967  275  326 67 123 
tmRNA  -13.708  153  164 601 612 
crsB  -13.414  133  181 452 505 
C0719  -12.984  62  98 889 922 
tpke70  -12.528  118  160 570 620 
ryfB  -12.510  123  140 58 79 
C0299  -12.039  1  51 252 292 
rdlD  -11.877  1  10 664 673 
dsrB  -11.748  55  73 769 786 
C0465  -11.469  12  31 608 633 
omrB  -11.428  6  46 751 790 
ssrS  -11.420  25  61 750 785 
*rdlC  -8.737  1  8 15 22 
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Figure 3.10  Predicted regions of pairing between sRNAs and RNA-IN 
according to INTARNA. Predictions are based on pairing at 37°C with a 
minimum seed region of 7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
SroG 
IS10 
GlmZ 
IS10 
RdlC 
IS10 
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The strategy I took to test potential sRNA-IS10 transposase mRNA 
interactions, was to make an in vitro transcribed transcript of both the sRNA 
candidate and IS10 transposase mRNA.  These transcripts were then incubated 
together at 37°C (the same temperature employed in the INTARNA program), 
and ran on a polyacrylamide gel to see if base pairing occurred.  A positive result 
in this ‘pairing’ assay would provide impetus for genetic studies.  An in vitro 
transcription template was made for these sRNAs by PCR amplifying a genomic 
preparation of NK5830F' with the primers specific for the corresponding RNA.  
The primer pairs BM31A/BM32A, BM33A/BM34A and BM35A/BM36A were used 
to amplify GlmZ, RdlC and SroG respectively.  The forward primer included the 
T7 RNA polymerase promoter (see Figure 3.4 for the general strategy).  RNA 
transcripts were made by T7 RNA Polymerase (NEB) using the T7 RNA 
polymerase promoter containing template of each sRNA.  The sRNAs were heat 
treated at 90°C for 2 minutes, placed on ice for 5 minutes then the pipetted on the 
side of a microfuge tube along with the first 160 nucleotides of 32P labeled RNA-
IN (IN-160) and centrifuged into Hfq buffer to ensure all binding reactions were 
started at the same time.  The reactions were incubated for 15 minutes at 37°C 
and loaded on to a 5.5% native polyacrylamide gel at 21V/cm to test for base 
pairing of the sRNA and RNA-IN (first 160 bp) transposase RNA.  Pairing was not 
detected between IS10 and SroG, GlmZ, or RdlC at any of the concentrations of 
sRNA:IN-160 tested (where the sRNA was in as much as 100 fold excess over 
RNA-IN) (Figure 3.11).  In contrast, when RNA-IN was in excess to GlmZ, some 
pairing was detected (Figure 3.11).   It is important to note that experiments 
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shown here are experiments done in the absence of Hfq. I was able to show that 
Hfq binds GlmZ (Figure 3.12), but I did not see stimulation in pairing efficiency 
when Hfq was titrated into a GlmZ-RNA-IN Pairing reaction (Data not shown).  
The in silico predictions I used to devise a list of potential sRNAs that could base 
pair with RNA-IN were based on conditions with the sRNA and mRNA at 37°C, 
and did not include Hfq.  If GlmZ is involved in IS10 regulation, we expect it to be 
in an Hfq dependent manner which would explain the increase in transposition in 
the absence of RNA-OUT and Hfq.  To address this we tested if Hfq binds GlmZ 
transcript.  32P labelled GlmZ was incubated for 15 minutes at 37°C with 
increasing concentrations of Hfq.  GlmZ binds Hfq and depending on the Hfq 
concentration can form up to 3 complexes (Figure 3.12). 
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Figure 3.11 Pairing of sRNAs to IS10 (bp1-160) only occurs when IS10 is in excess.  sRNAs were incubated at 
37°C in Hfq buffer and 32P labelled IS10 at the given ratios for 15 minutes.  An equal volume of 2x load mix was 
added to each reaction and samples were run on a 6% native polyacrylamide gel.  Bottom Right: 32P labelled 
GlmZ was incubated at 37°C in Hfq buffer and IS10 RNA at constant ratios for 15 minutes.  An equal volume of 2x 
load mix was added to each reaction and samples were run on a 6% native polyacrylamide gel. 
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Figure 3.12 Hfq binds GlmZ to form 3 protein-RNA complexes.  32P labelled 
GlmZ (GlmZ*) was incubated at 37°C in Hfq buffer with varying Hfq 
concentrations for 15 minutes.  An equal volume of 2x load mix was added to 
each reaction and samples were run on a 6% native polyacrylamide gel. 
 
 
3.7 Does limiting the availability of Hfq proteins in E.coli impact on IS10 
transposition frequency? 
In this section of the thesis I asked if reducing Hfq levels in the cell 
increases IS10 transposition frequency.  A proposed IS10 Hfq regulation model 
from Ross et a/. suggested that cellular stress may result in the titration of Hfq 
through over expression of sRNAs 18.  In support of this model, data suggest that 
the overexpression of an Hfq binding sRNA or mRNA can decrease sRNA 
directed regulation of a target gene 54,53.  The sRNAs DsrA, RhyB and MicC were 
chosen to titrate Hfq as they were effective Hfq titrators in the previously 
mentioned studies.  We also explored the effect of the sRNAs GlmZ and SroG on 
IS10 transposition frequencies.  GlmZ was chosen, due to the in vitro data 
suggesting IS10 can pair with it (Figure 3.11), and SroG due to its predicted 
binding to IS10 from lntaRNA (Figure 3.10), as well as the availability of a SroG 
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disruption strain in the laboratory.  To test if reduced Hfq levels result in differing 
transposition frequencies, 3 sRNAs, MicC, RhyB and DsrA, were cloned into 
pACYC184 under the control of the pLlac01 promoter.  Additionally, an IPTG 
inducible pLlac01 GlmZ construct was generously given to us by the Gottesman 
lab (NIH, Bethesda, MD).  The inducible sRNA containing plasmid were co-
transformed into NK5830 with a plasmid containing a kanamycin marked IS10 
element and plated overnight on LB containing 25 μg/mL of kanamycin and 10 
μg/mL of tetracycline at 37°C either in the presence of absence of IPTG.  MicC, 
RhyB and DsrA were induced with 1 mM IPTG, and GlmZ was induced with 100 
μM IPTG.  Resulting transformants were used to inoculate overnight cultures at 
37°C in LB broth with identical additives as the plates the colonies were picked 
from.  Overnight cultures were subcultured in 1 ml of LB broth and a standard 
mating out was performed (see Materials and Methods).  One mL of the overnight 
culture was used for total RNA isolation.  Total RNA was isolated using acid-
phenol extraction, quantified and equal amounts of total RNA underwent reverse 
transcription using primers specific to the sRNA.  A NK5830 F' containing a sroG 
gene disruption was also tested for a change in transposition frequency.  
Induction of MicC resulted in a 1.7 fold increase in transposition compared to 
non-induced.  GlmZ, RhyB and DsrA induction had no significant effect on 
transposition compared to their non-induced counter parts (Figure 3.14).  Semi-
quantitative RT PCR shows approximately a 110 fold increase in MicC RNA in 
the induced cells versus the uninduced cells and an approximately 20 fold 
increase in GlmZ RNA in the included cells verses the uninduced cells (Figure 
3.13). Overall, MicC overexpression caused a small increase in IS10 
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transposition and I suggest this may be due to limiting the availability of Hfq in the 
cell. In contrast, overexpression of a 2nd sRNA, GlmZ, did not influence IS10 
transposition frequencies. 
 
 
Figure 3.13 IPTG induced MicC expression (Top) and IPTG induced GlmZ 
expression (Bottom).  Cells NK5830 F’ cells transformed with a plasmid 
containing plLacO1 MicC or pLlacO1 GlmZ and were grown to exponential phase 
in the presence of 1 mM IPTG for MicC or 100 μM for GlmZ.  Total RNA was 
isolated and RT PCR was performed using reverse primers specific to MicC, 16S 
rRNA and GlmZ. 
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Figure 3.14 sRNA overexpression mating out assay (top and bottom-right).  
NK5830 F’ cells were co-transformed with an inducible sRNA plasmid and a 
marked IS10 element IS10 Kan (pDH502).  Cells were grown overnight in 
kanamycin and tetracycline (25 μg/mL and 10 μg/mL respectively) LB in either 
the presence or absence of IPTG (1 mM for top graph, 100 μM for bottom right) 
and then subcultured in LB in the presence or absence of IPTG (1 mM for top 
graph, 100 μM for bottom right).  The mating out assay was then performed.  
SroG disruption strain mating out assay (Bottom-Left): NK5830 cells as well 
as NK5830F’ with SroG replaced with a kanamycin gene were transformed with 
pDH502.  Cells were grown overnight in LB containing Ampicillin [50 μg/mL].  The 
mating out assay was then performed. 
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Overexpression of sRNAs can titrate out available cellular Hfq however; 
the physical amount of Hfq is unchanged.  To test if reducing Hfq expression 
levels (a percentage of the amount of Hfq in the cell) impacts on IS10 
transposition frequency I utilized a dksA disruption strain.  Loss of DksA has been 
shown to reduce Hfq levels by 50% in Shigella flexinari 55 and E. coli 54.  To 
introduce a dksA disruption into a strain suitable for the mating out assay, a P1 
phage lysate was produced by infecting MG1655 Δdks::tet (a gift from M. Cashel 
via S.  Gottesman) with P1 phages and transducing NK5830 F' with the resulting 
lysate.  NK5830F' transductants were verified by PCR to contain the tetracycline 
gene insertion in the dksA gene (DksA-). 
The dksA::tet insertion strain of our mating out strain was transformed with 
a ‘marked’ IS10 element (pDH502), grown overnight on LB plates containing 
kanamycin and then overnight cultures were set up with individual colonies in LB 
broth containing kanamycin.  The overnight cultures were subcultured in LB broth 
or LB broth containing tetracycline (to ensure the disruption was present).  The 
standard mating out protocol described in Materials and Methods was followed.  
There was a 3-fold increase in IS10 transposition seen between NK5830F' and 
DksA- NK5830F’ cells during our standard mating out conditions (37°C, grown to 
exponential phase on LB broth) (Table 3.4). This result indicates that down-
regulating Hfq expression results in a small increase in IS10Kan transposition.  
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Table 3.4 Ratios of transposition frequencies of NK5830F’ and its isogenic 
mutants. IS10 transposition frequencies in NK5830 F’ wildtype and mutant cells 
were determined from a mating out assay at 37°C (Normal conditions) based on 
two independent experiments with n=4, except the H-NS mutant which had only 1 
experiment with n=4. 
 
 
 
 
 
 
 
The transition of E. coli from exponential growth phase to stationary phase 
changes the expression profile and levels of many cellular proteins.  For example 
Azam et a/ suggest that Hfq, H-NS and IHF (all proteins shown to be involved in 
Tn10 transposition) levels all decreased after prolonged stationary phase 86.  
Additionally the sRNA expression profile of a cell will change under different 
growth conditions.  RpoS encodes a sigma factor that plays an important role in 
orchestrating changes in gene expression that facilitate a cell’s transition into 
stationary phase. In this section, I asked if stationary phase stress impacts IS10 
transposition frequency. A modified mating out protocol was devised in order to 
determine the effect of stationary phase stress on IS10 transposition frequencies.  
Our mating out strain, NK5830 F’, was transformed with pDH502 and grown 
overnight on LB kanamycin plates at 37°C then individual colonies were used to 
inoculate LB kanamycin broth [25 μg/ml] at 37°C.  The inoculum was then left for 
5 days without aeration on a bench top for growth, and then processed in a 
mating out assay. These stationary phase growth conditions resulted in a 9.8 fold 
Mutant/WT’ Ratio Standard 
Deviation 
hfq-/WT 33.14 0.84 
dksA-/WT 3.03 1.41 
rpoS-/WT 2.12 0.60 
hns-/WT 1.03 0.57 
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increase in IS10 transposition compared to our ‘standard’ mating out conditions 
where cells are grown to exponential phase prior to the mating procedure (Table 
3.5). This result suggests that growth conditions can alter IS10 transposition 
frequencies. 
To follow up on this observation that growth conditions can alter IS10 
transposition frequencies, I asked the question: does this 9.8 fold increase 
transposition events still occur in different genetic backgrounds?  The goal of this 
study was to determine the genetic dependencies on IS10 transposition 
frequencies under starvation conditions.  Three different genetic backgrounds 
(rpoS-, dksA- and hfq-) of our mating out strain (NK5830) were tested for an 
increase in IS10 transposition frequencies under ‘starvation’ conditions. When 
analyzing the growth curves of these mutants, it became apparent that only the 
rpoS- mutant provided a good comparison to the wildtype mating out strain as 
dksA- and hfq- cells did not grow well under these conditions (see Figure 3.15).  
Interestingly, there was no difference in transposition frequencies in the rpos 
mutant when comparing to room temperature growth to 37° C, but there is an 
increase in transposition in the wild type background.  A possible explanation for 
this could be the Hfq levels present in the two backgrounds, whereas higher Hfq 
levels may reduce transposition frequencies in the rpoS- mutant.  At 50 hours, 
both rpoS- and NK5830 cells appear to be towards the end of exponential phase, 
and at 110 hours, they both appear to be approaching death phase.  One ml 
aliquots of cells were obtained from RpoS or NK5830F' backgrounds and used to 
quantify Hfq levels by a semi-quantitative Western Blot (Figure 3.16).  There was 
no significant difference in levels in Hfq levels at either time point. Therefore, the 
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inability of rpoS- cells to support an increase in IS10 transposition upon 
‘stationary phase’ stress does not appear to be linked to Hfq levels. Nevertheless, 
this experiment has provided the 1st evidence that IS10 transposition is induced 
by stationary phase stress and that this induction is dependent on the 
transcription factor RpoS.  
Table 3.5: Transposition frequency ratios in different growth conditions. Ratio of 
transposition frequencies determined from a mating out assay at room temperature with 
no aeration divided (Starved) by the transposition frequency determined at 37°C with 
aeration (Normal) based on two independent experiments with n=4. 
 
 
 
 
Starved/Normal Ratio Standard 
Deviation 
N= 
'Starved’ 
N= 
‘Normal’ 
5830/5830 9.81 1.64 14 8 
dksA-/dksA- 2.65 1.59 9 8 
rpoS-/rpoS- 1.02 0.57 8 8 
hfq-/hfq- 0.15 1.23 10 10 
 82 
1.00E+00
1.00E+02
1.00E+04
1.00E+06
1.00E+08
1.00E+10
0 20 40 60 80 100 120
N
K
5
8
3
0
F
' 
C
F
U
/m
L
 (
L
o
g
1
0
) 
Time (hours) 
1.00E+00
1.00E+02
1.00E+04
1.00E+06
1.00E+08
0 20 40 60 80 100 120
H
fq
 C
F
U
/m
L
 (
L
o
g
1
0
) 
Time (hours) 
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
0 20 40 60 80 100 120
D
k
s
A
 C
F
U
/m
L
 (
L
o
g
1
0
) 
Time (hours) 
1.00E+00
1.00E+02
1.00E+04
1.00E+06
1.00E+08
1.00E+10
0 20 40 60 80 100 120
R
p
o
S
 C
F
U
/m
L
 (
L
o
g
1
0
) 
Time (hours) 
Figure 3.15 Growth curves of NK5830 F’ and its isogenic mutants with disruptions in rpoS, dksA, and 
hfq transformed with pDH502.  Cultures were inoculated with a 12 hour offset in order to obtain a time point 
every two hours (3 independent colonies at varying times).  Cells were taken out in 1 mL aliquots at each time 
point, spun down, suspended in 0.85% NaCl and diluted for plating.  LB plates containing kanamycin [25 
μg/mL] were incubated overnight at 37◦C and colonies were counted. The RpoS growth curve contains a large 
increase in cells per mL between 22 and 26 hours. This is likely due to having the 12 hour offset and missing 
the time point at 24 hours. One can see at time 0, there is one culture that started at 1 x 104 CFU/mL.This 
culture contains 100 times more starting cells than the other 3 cultures being analyzed, so after 26 hours of 
growth it will contain more cells than the other culture being measured. 
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Figure 3.16 Western blots of NK5830F’ and rpoS- cell lysates.  Cells were grown to either 50 hours or 110 hours at 
room temperature without aeration.  Cell volumes were normalized to 1 mL at an OD600 =0.6, and that volume was 
spun down and resuspended in 20μL of SDS load buffer (2% SDS, 10% glycerol, .06M Tris HCl pH6.8, .025% 
Bromophenol Blue), boiled for 300 seconds then loaded on a 14% SDS-PAGE gel (10μL load) and ran at 17V/cm until 
the Bromophenol Blue dye front reached the bottom of the gel.  Gel was transferred on PVDF membrane at 0.6mA/cm2 
of PVDF membrane.  PVDF membrane was blocked overnight in 5% fatfree milk (Nelson) dissolved in TBST buffer.  
Western blotting was done with a 1/100,000 dilution of α-hfq antibody (rabbit polyclonal) and a 1/4000 dilution of a 
mouse α-rabbit IgG (Promega).  P-lane represents 100 ng of purified Hfq.  H-lane contains cell lysate from hfq- cells 
(DBH16).  WT-lane contains cell lysate from wildtype cells (NK5830).  R-lane contains cell lysate from rpos- cells (DBH 
48). P-lane contains purified Hfq protein only. 
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Chapter 4 - Discussion 
4.1 Using bioinformatics to identify IS Elements that are under Hfq 
regulation. 
 In this work we successfully identified another Hfq regulated element, 
IS1413, by searching for Hfq binding sites of in IS Element transposase mRNA 
sequences, instead of physically working with the element first.  Further 
characterization of other elements found in Tables 3.1 and 3.2 may expand the 
list of Hfq regulated IS Elements from the current 3 (IS10 18, IS50 (Crystal 
McClellan thesis), and now IS1413 (this work)). 
 This bioinformatics approach to finding IS Elements that are candidates for 
Hfq regulation demonstrated several advantages over individually testing each IS 
Element for a change in transposition frequencies in the presence or absence of 
Hfq. First of all, there is a large data base of IS Element sequences available in 
one location in the IS finder database. In its original form, the IS finder data base 
makes a meta-analysis of all entries difficult; however this was overcome using a 
webcrawler and a parsing macro to put all of the Element information in one easy 
to search document. Once this document of all the IS-Elements was compiled, all 
of the IS Element information are found in a sortable and searchable 
spreadsheet.  Second of all, the Hfq binding site has been rigorously defined in 
sequence and structure composition. Hfq binding sites on mRNA species have 
been defined in terms of sequence such as the SELEX binding site 44, the polyA 
binding site 41, and the ARNx binding sites 
41 . Regions of RNA that bind Hfq are 
often followed by a hairpin (reviewed in 38). Finally, the high degree of 
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conservation between Hfq proteins in different bacteria, lead me to the 
expectation that Hfq binding sites will also be highly conserved in different 
bacteria. As mentioned previously, Pseudomonas Hfq relieves RpoS gene 
inactivation in E.coli containing Hfq disruptions74 and  Burkholderia cephacia 
IST408-SS7 Hfq relieves the slow growth phenotype that E.coli MC4100 ΔHfq 
exhibits 87. Overall, this method of identifying IS Elements that may be under Hfq 
control, remains a valuable tool in the study of how prevalent Hfq regulation is 
throughout the different families of IS Elements. 
There still remains some issues to address regarding using the ISFINDER 
searching strategy for Hfq regulated IS Elements. The first concern of this 
approach is it does not take into account the secondary structure of the IS 
Elements’ transposase mRNA. Hfq binding is dependent on both sequence and 
structure of the RNA species (reviewed in 38). I would predict that by adding the 
secondary structure parameter into this approach would result in fewer 
candidates for Hfq regulation. Future modifications of this approach to overcome 
this concern could include, a scoring system that first scores candidate IS 
Elements for containing the Hfq binding sequence, and then analyzing that region 
for secondary structures. Conversely, although we may have more candidates by 
not including the secondary structure parameter in our search, we are biasing the 
results for a high percentage of type II statistical errors, due to the stringency in 
the Hfq binding site searched.  Not all Hfq binding sites will contain the perfect 
consensus sequence AAYAAYAA found by Lorenz et al. 44, We are thus 
increasing the possibility of false negatives in this search.  Finally, the capacity of 
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Hfq to bind an RNA site tightly does not always translate into the interaction being 
biologically relevant. This phenomenon was observed in the Hfq binding site on 
the 3’ end of IS10’s transposase mRNA, which upon mutation did not result in 
any change in Hfq sensitivity. Despite these potential caveats of this 
bioinformatics approach to identifying Hfq regulation of IS Elements, I was 
successful in identifying IS1413, which did exhibit a change in transposition 
frequencies in the presence of Hfq. This approach does remain a good starting 
point to identify Hfq sensitive IS Elements to be followed up on using traditional 
genetic and in vitro studies. 
4.2 Hfq and IS1413 transposition: 
 These studies show that the frequency of IS1413 transposition and IS1413 
transposase expression both increase in the absence of Hfq. Following up on this 
observation, I tried to correlate this ‘Hfq effect’ with a validated Hfq binding site in 
the 5’ UTR of the IS1413 transposase mRNA. I did this by looking at mutations in 
the putative 5’ UTR of the IS1413 transposase mRNA. These mutations did not 
result in an increase of transposase expression in the presence of Hfq (unlike the 
hfq disruption). There are several possibilities why mutating the putative Hfq 
binding site did not result in the de-repression of IS1413 transposase expression 
in the presence of Hfq. The most obvious possibility is our identified binding site 
may not be a bona fide Hfq binding site in vivo. Our bioinformatics data and in 
vitro data support that Hfq does bind to this region, however in vivo several other 
factors would be involved in a successful binding interaction such as the 
accessibility of the binding site, or the availability of cellular Hfq. An interesting 
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result of the IS1413 transposase mutations we looked at was that it caused an 
overall increase in IS1413 transposase expression in both the presence and 
absence of Hfq (see Figure 3.1). The expectation of this study was that the 
mutants would have lower transposase expression in the presence of Hfq relative 
to the wild type translational fusions. These mutations we introduced may have 
inadvertently improved either the translation initiation or the transcript stability of 
IS1413. This overall increase in IS1413 transposase expression may overshadow 
any positive effects linked to the loss of Hfq binding to the transposase mRNA, 
and thus we would be unable to see any subsequent repression. More mutations 
will need to be made and analyzed for IS1413 to see if we are able to alleviate 
Hfq repression.  Our identified putative Hfq binding site in IS1413 was based on 
the stringent sequence AAYAAYAA, which did not allow for any substitutions in 
any position. The possibility remains that there may be other Hfq binding sites, 
that are not a perfect match, are downstream of the 5’UTR that Hfq is binding to 
down regulate IS1413 transposase expression. Finally, it is possible the Hfq 
effect on IS1413 transposition frequencies is indirect, and is actually due to the 
different genetic expression profiles between the wildtype NK5830 F’ cells, and 
its isogenic hfq disruption strain DBH16. 
 In this work on IS1413 we were able to show that IS1413 is active in E.coli 
and we were able to measure the expression of the IS1413 transposase gene in 
E.coli using a translational fusion. The Hfq status of E.coli influenced both IS1413 
transposition frequencies and transposase expression; both of these increased in 
an hfq- E.coli strain. We have has shown that IS1413 is an active element that 
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can transpose in E.coli with a transposition frequency of 3.7 x 10-5 transposition 
events per mL of mating mix in the presence of Hfq and 5.0 x 10-4 transposition 
events per mL of mating mix in the absence of Hfq. These results suggest that 
Hfq has a repressing role on IS1413 expression.  This is more evidence for the 
notion that Hfq is a general regulator of IS Elements. Subsequently, with Hfq 
being linked to cellular stress responses 88, these results provide a possible 
pathway for linking IS1413 transposition to cellular stress pathways. In other 
words, under certain conditions the host may be more permissive to transposition 
events which may result in the transposon induced gene expression changes, 
such as the expression of the tft operon to allow for the utilization of phenol 
compounds as a carbon source.  
 The observation that IS1413 is active in E. coli is an example of how IS 
Elements can be promiscuous carriers of genes from one bacterial population to 
another.  Since IS1413 is also active in Burkholderia 56 , this opens up the 
possibility that Burkholderia and E. coli could potentially exchange genes through 
IS1413 mediated transposition.  This gene exchange would entail IS1413 
carrying additional genes with it during a transposition event onto a conjugative 
plasmid and transferring it to another species.  Species of the genus Burkholderia 
are commonly found in water in soil and sometimes as plant or human pathogens 
89.  E. coli is primarily found in the lower intestine of warm blooded animals as 
well as in water, sediment and soil 90.  It is very possible these two organisms 
could be found in a common habitat such as soil, and share genes through 
conjugation and transposition events.  The identification of IS1413 being active in 
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E. coli opens up the possibility that it could be an agent of pathogenicity transfer 
between the two organisms.  For example, if IS1413 flanks a pathogenicity gene 
in E.coli or an antibiotic resistance factor, it may move onto a transmissible 
plasmid (such as the F-factor). If this IS1413 harbouring pathogenic E.coli is 
passed into soil by an infected animal and Burkholderia phenoltripix is also 
present, through conjugation Burkholderia phenoltripix may acquire the ability to 
infect an animal that consumes that soil (See Figure 1.1 for mechanisms that 
could account for this). 
Our results show Hfq influences IS1413 expression and transposition 
frequencies; this provides us with further understanding of how IS1413 
transposition is regulated. IS1413 is not a well-studied transposon. Prior to this 
study, IS1413 was identified to be active in Burkholderia phenoltripix 56. 
Subsequently, it was demonstrated that IS1413 can up regulate the tft operon in 
Burkholderia phenoltripix. The first gene in the tft operon is involved in the 
breakdown of 2,4,5 tricholorophenol (i.e. Agent Orange) 91. By further 
understanding the regulation of IS1413 and its activation of the tft operon, one 
could potentially utilize Burkholderia phenoltripix for bioremediation of areas 
polluted with 2, 4, 5 tricholorophenol compounds such as Agent Orange. 
Ultimately, one would hope on identifying conditions that would facilitate the up 
regulation of the tft operon and thus facilitate the degradation of these toxic 
compounds. 
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4.3 Hfq regulation of IS10 
An objective of my thesis was to fully identify how Hfq represses IS10 
transposase. There were two main reasons for why I looked at Hfq regulation of 
IS10 transposase. First of all, my bioinformatics screen predicted that there is an 
Hfq binding site in the 3’ end of the transposase transcript. Secondly, previous 
studies by Ross et al. suggest there is Hfq regulation independent of the IS10 
transposase transcript. I looked at the possibility that Hfq regulates IS10 
transposase, at least in part, by binding the 3’ end of the transposase transcript 
where my bioinformatics analysis predicted the existence of an Hfq binding site.  
An example of Hfq binding the 3’ end of a transcript and the effects it can 
have are seen in the interactions of cspA mRNA and Hfq.  Hfq protects cspA 
mRNA from RNase E mediated degradation. It also increases the length of a 
polyA tail due to polyadenylate polymerase 92. With a putative 3’ binding site in 
the IS10 transposase, I decided to characterize the 3’ end of the IS10 
transposase transcript to look for evidence of polyadenylation. The presence of 
polyadenylation on the transposase transcript would have been consistent with 
the 3’ SELEX site and Hfq playing a role in processing of the transcript. Results 
the 3’ RLM-RACE did not show any evidence of polyadenylation of either IS10L 
or IS10R.  The identified end may be a processed transcript that occurs following 
transcription.  Nonetheless, I did successfully define a 3’ end for both IS10R and 
IS10L. Previous studies have never determined this prior to this work. Future 
directions to confirm the true 3’ end of IS10 could include an RNA protection 
assay to verify the predicted 3’ end of IS10 predicted by the 3’ RLM-RACE. 
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Understanding precisely how the IS10 transcript terminates may provide some 
insight into the effect Hfq has on reducing its half-life. 
To characterize the putative Hfq binding site in the 3’ end of IS10 transposase 
transcript, I utilized RNA-Hfq binding studies and transposase expression studies. 
Through binding studies, I found that Hfq binds to the 3’ site when a portion of the 
transposase transcript was studied. When trying to initially determine the regions 
that are important for Hfq regulation of IS10, different lengths of IS10 were used 
to make translational fusions with LacZ.  A general trend observed in this set up 
was the longer the transcript, the more active the fusion was.  Generally, Hfq 
repressed the overall activity of the transcript in all of the translational fusions 
about 3 fold.  However, the fusions containing very small amounts of IS10 (180 
bp or 290 bp) have transposase expression barely above the ‘cells only’ control.  
One possibility as to why the longer fusions were more active is due to the 
shorter transcripts not being able to fold properly. Improperly folded transcripts 
would have a greater chance of being degraded by single stranded specific 
RNases. When the 3’ SELEX site in the IS10 transposase LacZ translational 
fusions was disrupted through site directed mutagenesis, Hfq repression was not 
relieved. There are a few possible reasons for why we were unable to de-repress 
Hfq regulation of IS10 transposase expression. First, Hfq may be unable to bind 
the 3’ SELEX site in the IS10 transposase transcript in vivo. Second, Hfq may be 
able to bind the 3’ SELEX site in the IS10 transposase transcript in vivo, however 
under the conditions we tested it may be missing another factor required to elicit 
a biological response. This missing biological factor could be an sRNA that is 
only expressed under certain stress conditions. 
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Overall, the bioinformatics approach I took to identify Hfq regulation sites in 
transposase transcripts was successful in the case of IS1413, but not for IS10. 
This project successfully identified a new Hfq-regulated transposase, IS1413, 
however this may be fortuitous.  Further characterization of the sensitivity of 
transposase expression to Hfq of my bioinformatics identified elements and a 
random list of IS Elements would help put my approach to the ultimate test. If my 
bioinformatics approach results in a higher proportion of Hfq sensitive 
transposases compared to the random list, this would suggest that the initial in 
silico screen provides a list of candidates that one should follow up on. 
 
4.4 RNA-IN has an Hfq binding site in the 3’ end and it may be relevant 
under certain physiological conditions. 
 The data from the 3’ RLM-RACE data suggests that there may not be any 
post transcriptional modifications of IS10 (Figure 3.3).  In vitro binding studies 
show that Hfq is able to tightly bind the 3’ end of RNA-IN and mutating the 
putative Hfq binding sequence reduces the apparent binding affinity Hfq.  So if 
Hfq binds the transcript, why do we see no effect in the mating out assay when 
we mutate the 3’ end? One possibility is that under the conditions used for the in 
vitro data favoured the binding of Hfq whereas as the mating out conditions did 
not permit Hfq binding.  Hfq binds not only in a sequence specific manner but 
also in a secondary structure dependent manner.  For example, in the case of 
Hfq dependent sRNAs the basic requirements for productive Hfq binding include 
a hairpin flanked by U rich regions 76.  One could envision conditions that may 
alter secondary structures of RNA molecules such as cold shock or extreme heat.  
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An example of this is in RNA thermometers where mRNA transcripts form self-
inhibiting structures blocking their RBS, but when presented with specific 
environmental conditions they undergo a conformational change which permits 
translation (reviewed in 93).  It is possible that the conditions we tested for a 
phenotype in both the β-galactosidase assay and the mating out assay are not 
permissive for the appropriate secondary structure to form and thus no productive 
Hfq binding occurs (See Figure 4.1).  Another possibility remains that the 
function of the 3’ end of the RNA molecule may act as an Hfq chelator under 
certain conditions, as a method of the element to modulate cellular Hfq 
availability and thus increasing the amount of RNA-IN transcript available in the 
cell and thus more transposition under times of stress (See Figure 4.1).  Future 
directions should be to identify conditions that alter the IS10 transposition 
frequency of Hfq+ cells but not Hfq- cells.  Such a condition may have 
inadvertently been identified already with the room temperature data (discussed 
further below). 
4.5 Is IS10 transposition regulated by an sRNA 
 In this study I utilized another bioinformatics approach (INTARNA) to 
define sRNAs that may regulate IS10 transposase expression.  From the list of 
potential sRNA-IS10 mRNA interactions, I studied 3 sRNAs: GlmZ, SroG and 
RdlC. In vitro binding studies with HFQ revealed that GlmZ was the only of the 3 
sRNAs that pairs with the 5’ end of IS10 transposase mRNA. However, 
overexpression of GlmZ did not have an impact on IS10 transposition frequencies 
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in a mating out assay. These results suggest that the weak in vitro interaction 
between IS10 and GlmZ is not biologically relevant.  
 
Figure 4.1 Model for potential conditions that may change the ability for Hfq 
to bind a transcript. (Left) Growth of E. coli at our standard lab conditions 
(37°C, with aeration) is not permissive to 3’ RNA-IN Hfq regulation, resulting in 
Hfq being available to promote base pairing of RNA-IN and RNA-OUT, resulting 
in inhibited IS10 transposase translation and subsequence degradation of the 
mRNA transcript. (Right) In growth conditions that alter the folding of the RNA-IN 
transcript, Hfq may be able to bind the 3’ region resulting in 2 possible 
mechanisms. The first possibility is that Hfq may get titrated away from the 5’ 
binding site, resulting in reduced RNA-IN/RNA-OUT pairing and ultimately 
increased translation. The second possibility is that Hfq may facilitate degradation 
under certain growth conditions either through an expressed sRNA specific to 
those conditions, or a general nuclease mediated degradation (such as PNPase). 
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4.6 Does modulation of Hfq levels have an impact on IS10 transposition? 
 Ross et al suggest a mechanism of Hfq regulation of IS10 where stress 
environments promote the overexpression of sRNAs which in turn occupy Hfq 
RNA binding sites. This ‘chelating’ effect on Hfq may result in less Hfq available 
in the cell to promote the pairing of RNA-OUT and RNA-IN, resulting in a 
reduction of IS10 transposase expression 18. The initial inducer of sRNA 
expression is often a change in environmental conditions, and the bacterial cell 
can modulate gene expression through the expression of sRNAs. Therefore, 
under certain stresses, Hfq binding sRNAs can be expressed which bind Hfq, de-
repressing the Hfq down regulation of IS10 transposase expression and 
consequently increasing IS10 transposition frequencies. 
 The overexpression of MicC in our wildtype (Hfq+) mating out E.coli strain 
resulted in an increase of in IS10 transposition of 1.7 fold compared to the 
uninduced and vector only controls. MicC has already been shown in prior 
studies (53,54), to alter the expression of genes that are subject to Hfq repression 
or activation. Furthermore, I have identified a growth condition where forcing cells 
to incubate for prolonged periods in stationary phase that results in a 10 fold 
increase in IS10 transposition frequencies in wildtype cells, compared to normal 
growth conditions but not in an rpoS gene disruption strain. This is the first study 
done that links RpoS to a decrease in IS10 transposition frequencies when cells 
are in stationary phase. 
 The observation that MicC overexpression results in an increase of 10 fold 
in IS10 transposition frequencies suggests a possible link between cellular stress 
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and IS10 transposition. For example, MicC sRNA expression is induced when 
E.coli cells are exposed to cellular stresses such as low temperatures (24°C), 
osmotic shock, the herbicide Paraquat, and when grown in conditions where 
glycerol is the only carbohydrate source 37. If these cellular stresses induce MicC 
expression, and MicC expression results in an increase in IS10 transposition, is it 
possible that these cellular stresses result in increased IS10 transposition? 
Follow up experiments on the effect of sRNA overexpression on IS10 
transposition studies should focus on these stresses that may increase IS10 
transposition frequencies. These studies will help us understand the role 
transposition of transposable elements as a possible mechanism for cells to 
adapt to cellular stress. 
 Previous studies have already been done on the role of IS10 and stress 
adaptation of the cell.  For example, studies have been to on the effects of UV 
light induction of IS10 transposition 94. Another study was done on the osmotic 
stress adaption of rpoS deletion strains of E.coli, where the authors found that 
RpoS deletion strains consistently adapted to osmotic stress through IS10 
transposition in front of the otsBA operon (an RpoS dependent operon)95. This 
study is the first one to directly link RpoS as a regulator of IS10 transposition in 
terms of transposition frequencies in stationary phase. It is also the first study to 
link the sRNA MicC to IS10 transposition. 
Follow up experiments to test the how Hfq levels impact IS10 transposition 
rates should include using microarray data to determine how gene expression 
profiles change in wild type and mutants with the rpos gene disruption in the two 
growth conditions we analyzed in this work.  Using these expression profiles and 
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through gene deletion strains of E.coli, we could focus on specifically how the 
rpoS mutant is down regulating IS10 transposition.  It would be interesting to see 
the effects of our stationary phase growth conditions on known regulators of IS10 
transposition such as H-NS (a positive regulator of IS10 transposition) and 
Integrative Host Factor (IHF) (a host factor that promotes end pairing of the IS10 
transpososome.). The effect of stationary phase and IHF and H-NS have already 
been studied by Azam et al. where the abundance of IHF actually increase as 
well as the abundance of H-NS actually decreased by 40% at stationary phase. 
Follow up experiments to how growth conditions can affect IS10 transposition 
frequencies should include the characterization of the minimal amount of time of 
cell growth required to observe the increase of IS10 transposition frequencies in 
wildtype cells. Furthermore, an experiment testing different conditions should be 
conducted so we can really understand the specific factors that contribute to the 
increase in IS10 transposition, for example was it the lower temperature that 
resulted in the increase of transposition frequencies or was it the stationary 
phase? The most interesting follow up experiments should really characterize the 
genetic landscape of the rpoS disruption strain and the wildtype strain under the 
stationary phase growth conditions. It is intriguing as to why the wildtype strain 
has an increase in IS10 transposition yet the rpoS deletion strain maintains the 
same IS10 transposition frequency when grown into exponential phase.  Further 
experiments are required to elucidate just how RpoS is down regulating IS10 
under stationary phase growth conditions and whether or not this is a direct effect 
or due to the induction of an sRNA or the up regulation of a stationary phase 
response gene. 
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 This work has further explored the how host factors in bacteria regulate 
the expression of mobile genetic elements. In this work I have provided another 
example of an Hfq repressed IS Element (IS1413) as well as a growth condition 
that increases IS10 transposition elements in the presence of RpoS but not in the 
absence.  These findings provide a greater glimpse into factors that affect the 
mobility and expression of IS Elements in bacterial populations. By understanding 
what permits IS Element mobility and conditions that promote IS Element 
mobility, we are one step closer to understanding how we can control the 
movement of mobile genes in populations. If we eventually can control the 
movement of mobile genetic elements in populations, we can use these mobile 
genes for the benefit of the environment through bioremediation (such as in the 
case of IS1413) or to prevent the rampant spread of antibiotic resistance genes 
through bacterial populations in our health care facilities.  
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Appendix 1- Obtaining a compiled list of IS Elements from the IS Finder 
database. 
 In order to search the IS Finder database for sequences that contained 
putative Hfq binding sites, the sequences had to be compiled into a series of files 
that could be sorted and searched.  In their native state, the sequences had to be 
accessed one by one on the IS Finder database; searching the 3478 active links 
in the database one by one was not a viable option.  Firstly, a list of urls of each 
element entry had to be compiled.  This was achieved by searching for each IS 
Family number one by one (IS1, IS3, IS4, IS5, IS6, IS21, IS30, IS66, IS91, IS110, 
IS200, IS605, IS256, IS481, IS630, IS982, IS1380, ISAs1, ISL3, Tn3, IS1595, 
IS1182, IS1634, ISH3, IS701) and copying the IS Element names into a Microsoft 
Excel 2010 worksheet in column A.  All IS Finder urls have a common address of 
“http://www-is.biotoul.fr/index.html?is_special_name=” so by using the 
concatenate function of MS Excel 2010, one can paste the following function in 
column B to obtain a list of URLs to be searched: 
 “CONCATENATE("http://wwwis.biotoul.fr/index.html?is_special_name=",A
1)” 
This list of URLs was then pasted into WEBSPHINX77.  Using the concatenate 
function within WEBSPHINX77, all the information about the elements within each 
family was merged into one text file (.txt), which was then parsed as described 
below. 
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 Script A1.1 contains the find and replace script I used to parse the IS 
Finder Data base into a tab deliminated document.  The scripting language is 
Microsoft Visual Basic for Applications.  Extra text was removed from the 
compiled IS Finder database to conserve computer resources and the following 
fields remained: Element, Host, Transposition Determined, IS_Sequence, 
Comments, and References.  The resulting document allowed for an Excel 2010 
workbook to be made, so all elements within each IS-Family could be searched 
for the putative Hfq binding sites AAYAAYAA and AYAATAA, using Microsoft 
Excel’s built in find function.  Due to the variability of IS Elements in GC content, 
a probability (depicted as a P-Value in Tables 3.1 and 3.2) was also calculated of 
how likely it was to find the number of SELEX sites I did, taking into account the 
length and GC content of each element.  For example, if an element is very long 
and has an abundance of adenine and thymine bases, one would expect to find 
more SELEX sites compared to an IS Element with a very high GC content.  This 
was accomplished using a cumulative binomial distribution which gives the 
probability of finding exactly 1 SELEX site in IS10 for example.  Outlined below 
are two calculations for the IS10 Element for both SELEX sites AAYAAYAA 
(Calculation A1.1) and AYAATAA (Calculation A1.2). 
Calculation A1.1: The calculation of the probability of finding exactly 1 
AAYAAYAA SELEX site in the IS10 Insertion Sequence transposase mRNA. 
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Let p represent probability 
Sequence = AAYAAYAA 
Length = 1329 bp 
Number of potential sequences with a stretch of 8 nucleotides = 1329-7 
Number of trials = 1322 
GC Content = 44% 
p of G = 0.22 (or 22%) 
p of C = 0.22 (or 22%) 
p of A = 0.28 (or 28%) 
p of T = 0.28 (or 28%) 
 
 
 
                                                 
 
pAAYAAYAA= 0.0001205 
In this case of using the binomial distribution a success would be the SELEX site 
is present.   
The binomial distribution is represented by: 
      
  
        
           
For IS10 we found 1 SELEX site over 1329bp so: 
 x = 1 
N = 1322 
      
     
           
                              
                                    
          
Calculation A1.2: The calculation of the probability of finding exactly 1 
AYAATAA SELEX site in the IS10 Insertion Sequence transposase mRNA. 
 
Let P represent probability 
Sequence = AYAATAA 
Length = 1329 bp 
Number of potential sequences with a stretch of 8 nucleotides = 1329-7 
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Number of trials = 1322 
GC Content = 44% 
P of G = 0.22 (or 22%) 
P of C = 0.22 (or 22%) 
P of A = 0.28 (or 28%) 
P of T = 0.28 (or 28%) 
 
                                      
pAYAATAA= 0.00024 
 
In this case of using the binomial distribution a success would be the SELEX site 
is present.   
The binomial distribution is represented by: 
      
  
        
           
For IS10 we found 1 SELEX site over 1329bp (1322 trials) so: 
 x = 1 
N = 1322 
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Script A1.1: Visual Basic for Applications macro code used to parse IS Finder 
files for export into searchable files. 
Sub IS_PARSER() 
'Start the script at the very top of the document 
Selection.HomeKey Unit:=wdStory 
 
' allows Wild card to recognize ^p as $ 
'Find within the selected text.  In this case because no text is selected, the 
whole document is searched. 
 With Selection.Find 
 ' What string are you looking for 
  .Text = "^p" 
 ' What would you like to replace it with? 
  .Replacement.Text = " $^p" 
 ' Search forward in the document  
  .Forward = True 
 ' Ensures the whole document is searched 
  .Wrap = wdFindContinue 
 ' Wildcards are disabled 
  .MatchWildcards = False 
' Every instance of the word is replaced 
  .Execute Replace:=wdReplaceAll 
 End With 
 ' allows Wild card to recognize ^v as $ 
 With Selection.Find 
  .Text = "^v" 
  .Replacement.Text = " $^v" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 'Remove the First line of Each Entry 
 With Selection.Find 
  .Text = "Result of your query $^p" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
 'remove tabs to deliminate wanted fields 
  With Selection.Find 
  .Text = "^t" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
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 'Remove the First line of Each Entry 
 With Selection.Find 
  .Text = "Result of your query $^p" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
 'Removes all text between "Synonyms" and "Hosts" and replaces it with 
"Hosts:" 
  With Selection.Find 
  .Text = "SynonymsIsoFamilyGroup*OriginHosts" 
  .Replacement.Text = "Hosts:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters enabled 
  .MatchWildcards = True 
  .Execute Replace:=wdReplaceAll 
 End With 
 
 'Put a tab character in front of "Hosts:" 
  With Selection.Find 
  .Text = "Hosts:" 
  .Replacement.Text = "^tHosts:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Enable Wildcard, removes text between Accension and Transposition 
  With Selection.Find 
  .Text = "Accession NumberLengthIRDR*Transposition:" 
  .Replacement.Text = "Transposition:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = True 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Disable Wildcard, Tab deliminate Transposition field 
  With Selection.Find 
  .Text = "Transposition:" 
  .Replacement.Text = "^t Transposition" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
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'Delete "*" make sure wild cards are disabled, or you will lose all your text 
  With Selection.Find 
  .Text = "*" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Delete Sequence BTW ORF and IS_SEQ; Enable Wild Card, 
  With Selection.Find 
  .Text = "ORF:*IS_SEQ:" 
  .Replacement.Text = "IS_SEQ:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Enabled again 
  .MatchWildcards = True 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Tab Deliminate IS_SEQ field 
  With Selection.Find 
  .Text = "IS_SEQ:" 
  .Replacement.Text = " ^t IS_SEQ:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Delete the text between IS_PEP: and Comments 
  With Selection.Find 
  .Text = "IS_PEP:*Comments:" 
  .Replacement.Text = "Comments" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Enabled again 
  .MatchWildcards = True 
  .Execute Replace:=wdReplaceAll 
 End With 
 
'Tab deliminates Comments: 
  With Selection.Find 
  .Text = "Comments" 
  .Replacement.Text = "^t Comments:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Enabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
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' Remove all paragraph breaks #This will take awhile 
  With Selection.Find 
  .Text = "^p" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 ' Separates each entry as a new paragraph 
  With Selection.Find 
  .Text = "Page ^#" 
  .Replacement.Text = "^p Page 1" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
' Tab Deliminates References Section 
  With Selection.Find 
  .Text = "References:" 
  .Replacement.Text = "^t References:" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
' Delete $ place holders 
  With Selection.Find 
  .Text = "$" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
' Delete webpage breaks 
  With Selection.Find 
  .Text = "-" 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
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 'Replace Page # with IS_ELEMENT Tab delimited 
  
 With Selection.Find 
  .Text = "Page ^#^#^#" 
  .Replacement.Text = "^t IS_ELEMENT: " 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 With Selection.Find 
  .Text = "Page ^#^#" 
  .Replacement.Text = "^t IS_ELEMENT: " 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 With Selection.Find 
  .Text = "Page ^#" 
  .Replacement.Text = "^t IS_ELEMENT: " 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
'Replace IS Finder URL with ISELEMENT name 
With Selection.Find 
  .Text = "<[http://wwwis.biotoul.fr/is/scripts/is_spec.php?name=" 
  .Replacement.Text = "^p[" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 'Replace Delete double IS_Element 
With Selection.Find 
  .Text = "^p" 
  .Replacement.Text = "$" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Disabled again 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
With Selection.Find 
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  .Text = "$*$" 
  .Replacement.Text = "^p" 
  .Forward = True 
  .Wrap = wdFindContinue 
  'Wildcard characters Enabled again 
  .MatchWildcards = True 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 'Remove Field Names for proper Export as a Table  
 With Selection.Find 
  .Text = " IS_ELEMENT:  " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
 
With Selection.Find 
  .Text = "Hosts: " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 With Selection.Find 
  .Text = " IS_SEQ: " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
With Selection.Find 
  .Text = " Comments: " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
 With Selection.Find 
  .Text = " References: " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
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 With Selection.Find 
  .Text = " Transposition " 
  .Replacement.Text = "" 
  .Forward = True 
  .Wrap = wdFindContinue 
  .MatchWildcards = False 
  .Execute Replace:=wdReplaceAll 
 End With 
  
'Move to the top of the document and Title Fields for Excel export 
  
 Selection.HomeKey Unit:=wdStory 
  Selection.TypeText (vbTab & "IS_Element" & vbTab & "Host" & vbTab & 
"Transposase Tested" & vbTab & "IS_SEQ" & vbTab & "Comments" & vbTab & 
"References" & vbCrLf) 
   
 
 End Sub 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
References 
1. Ochman, H., Lawrence, J. G. & Groisman, E. a Lateral gene transfer and 
the nature of bacterial innovation. Nature 405, 299–304 (2000). 
2. Lawrence, J. G. & Ochman, H. Molecular archaeology of the Escherichia 
coli genome. Proceedings of the National Academy of Sciences of the 
United States of America 95, 9413–7 (1998). 
3. Buchanan-Wollaston, V., Passiatore, J. E. & Cannon, F. The mob and oriT 
mobilization functions of a bacterial plasmid promote its transfer to plants. 
Nature 327, 617–618 (1987). 
4. Heinemann, J. A. & Sprague Jr, G. F. Bacterial conjugative plasmids 
mobilize DNA transfer between bacteria and yeast. Nature 340, 205–209 
(1989). 
5. Davies, J. Inactivation of antibiotics and the dissemination of resistance 
genes. Science (New York, N.Y.) 264, 375–82 (1994). 
6. Ross, D. G., Swan, J. & Kleckner, N. Physical structures of Tn10-promoted 
deletions and inversions: role of 1400 bp inverted repetitions. Cell 16, 721–
31 (1979). 
7. Wang, A. & Roth, J. R. Activation of silent genes by transposons Tn5 and 
Tn10. Genetics 120, 875–885 (1988). 
8. Burrus, V., Pavlovic, G. & Decaris, B. Conjugative transposons: the tip of 
the iceberg. Molecular 46, 601–610 (2002). 
9. Lessie, T. G., Hendrickson, W., Manning, B. D. & Devereux, R. Genomic 
complexity and plasticity of Burkholderia cepacia. FEMS microbiology 
letters 144, 117–28 (1996). 
10. Shoemaker, N. Tetracycline-dependent appearance of plasmidlike forms in 
Bacteroides uniformis 0061 mediated by conjugal Bacteroides tetracycline 
resistance elements. Journal of bacteriology 170, 1651–7 (1988). 
11. Kleckner, N. Mobile DNA. Cell 60, 227–268 (1989). 
12. Shen, M. & Raleigh, E. Physical analysis of Tn10-and IS10-promoted 
transpositions and rearrangements. Genetics 369, 359–369 (1987). 
13. Morisato, D., Way, J. C., Kim, H. J. & Kleckner, N. Tn10 transposase acts 
preferentially on nearby transposon ends in vivo. Cell 32, 799–807 (1983). 
 
 
111 
14. Kleckner, N. Regulation of transposition in bacteria. Annu. Rev. Cell Bioi. 
1990. 6, 297–327 (1990). 
15. Roberts, D., Hoopes, B. C., McClure, W. R. & Kleckner, N. IS10 
transposition is regulated by DNA adenine methylation. Cell 43, 117–30 
(1985). 
16. Haniford, D. B. Transpososome dynamics and regulation in Tn10 
transposition. Critical reviews in biochemistry and molecular biology 41, 
407–24 (2006). 
17. Sakai, J., Chalmers, R. M. & Kleckner, N. Identification and 
characterization of a pre-cleavage synaptic complex that is an early 
intermediate in Tn 10 transposition end fragments standard ( S ) long ( L ). 
EMBO Journal 14, 4374–4383 (1995). 
18. Ross, J., Wardle, S. J. & Haniford, D. B. Tn10/IS10 transposition is 
downregulated at the level of transposase expression by the RNA-binding 
protein Hfq. Molecular microbiology 78, 607–21 (2010). 
19. Beich-Frandsen, M., Večerek, B., Sjöblom, B., Bläsi, U. & Djinović-Carugo, 
K. Structural analysis of full-length Hfq from Escherichia coli. Acta 
crystallographica. Section F, Structural biology and crystallization 
communications 67, 536–40 (2011). 
20. Møller, T. et al. Hfq: a bacterial Sm-like protein that mediates RNA-RNA 
interaction. Molecular cell 9, 23–30 (2002). 
21. Séraphin, B. Sm and Sm-like proteins belong to a large family: identification 
of proteins of the U6 as well as the U1, U2, U4 and U5 snRNPs. The 
EMBO journal 14, 2089–98 (1995). 
22. Gottesman, S. & Storz, G. Bacterial Small RNA Regulators: Versatile Roles 
and Rapidly Evolving Variations. Cold Spring Harbor perspectives in 
biology (2010).doi:10.1101/cshperspect.a003798 
23. Mikulecky, P. J. et al. Escherichia coli Hfq has distinct interaction surfaces 
for DsrA, rpoS and poly(A) RNAs. Nature structural & molecular biology 11, 
1206–14 (2004). 
24. Zhang, A., Wassarman, K. M., Ortega, J., Steven, A. C. & Storz, G. The 
Sm-like Hfq protein increases OxyS RNA interaction with target mRNAs. 
Molecular cell 9, 11–22 (2002). 
 
 
112 
25. Soper, T. J. & Woodson, S. a The rpoS mRNA leader recruits Hfq to 
facilitate annealing with DsrA sRNA. RNA (New York, N.Y.) 14, 1907–17 
(2008). 
26. Yarchuk, O., Jacques, N. & Guillerez, J. Interdependence of translation, 
transcription and mRNA degradation in the lacZ gene. Journal of molecular 
581–596 (1992).at 
<http://www.sciencedirect.com/science/article/pii/002228369290617S> 
27. Vytvytska, O., Moll, I. & Kaberdin, V. Hfq ( HF1 ) stimulates ompA mRNA 
decay by interfering with ribosome binding. Genes &amp; 14, 1109–1118 
(2000). 
28. Isabella Moll, Taras Afonyushkin, Oresta Vytvytska, V. R. K. Coincident Hfq 
binding and RNase E cleavage sites on mRNA and small regulatory RNAs. 
Rna 9, 1308–1314 (2003). 
29. Massé, E., Escorcia, F. E. & Gottesman, S. Coupled degradation of a small 
regulatory RNA and its mRNA targets in Escherichia coli. Genes & 
development 17, 2374–83 (2003). 
30. Mohanty, B. K., Maples, V. F. & Kushner, S. R. The Sm-like protein Hfq 
regulates polyadenylation dependent mRNA decay in Escherichia coli. 
Molecular microbiology 54, 905–20 (2004). 
31. O’Hara, E. B. et al. Polyadenylylation helps regulate mRNA decay in 
Escherichia coli. Proceedings of the National Academy of Sciences of the 
United States of America 92, 1807–11 (1995). 
32. Thomason, M. K. & Storz, G. Bacterial antisense RNAs: how many are 
there, and what are they doing? Annual review of genetics 44, 167–88 
(2010). 
33. Sorek, R., Kunin, V. & Hugenholtz, P. CRISPR--a widespread system that 
provides acquired resistance against phages in bacteria and archaea. 
Nature reviews. Microbiology 6, 181–6 (2008). 
34. Simons, R. W. & Kleckner, N. Translational control of IS10 transposition. 
Cell 34, 683–91 (1983). 
35. Udekwu, K. I. Transcriptional and post-transcriptional regulation of the 
Escherichia coli luxS mRNA; involvement of the sRNA MicA. PloS one 5, 
e13449 (2010). 
 
 
113 
36. Altuvia, S., Weinstein-Fischer, D., Zhang, a, Postow, L. & Storz, G. A small, 
stable RNA induced by oxidative stress: role as a pleiotropic regulator and 
antimutator. Cell 90, 43–53 (1997). 
37. Chen, S., Zhang, A., Blyn, L. B. & Storz, G. MicC , a Second Small-RNA 
Regulator of Omp Protein Expression in Escherichia coli. Society 186, 
6689–6697 (2004). 
38. Vogel, J. & Luisi, B. F. Hfq and its constellation of RNA. Nature reviews. 
Microbiology 9, 578–89 (2011). 
39. Salim, N. N., Faner, M. a, Philip, J. a & Feig, A. L. Requirement of 
upstream Hfq-binding (ARN)x elements in glmS and the Hfq C-terminal 
region for GlmS upregulation by sRNAs GlmZ and GlmY{dagger}. Nucleic 
acids research 1–12 (2012).doi:10.1093/nar/gks392 
40. Brennan, R. G. & Link, T. M. Hfq structure, function and ligand binding. 
Current opinion in microbiology 10, 125–33 (2007). 
41. Link, T. M., Valentin-Hansen, P. & Brennan, R. G. Structure of Escherichia 
coli Hfq bound to polyriboadenylate RNA. Proceedings of the National 
Academy of Sciences of the United States of America 106, 19292–7 
(2009). 
42. Takada, a, Wachi, M., Kaidow, a, Takamura, M. & Nagai, K. DNA binding 
properties of the hfq gene product of Escherichia coli. Biochemical and 
biophysical research communications 236, 576–9 (1997). 
43. Panja, S. & Woodson, S. a Hexamer to Monomer Equilibrium of E. coli Hfq 
in Solution and Its Impact on RNA Annealing. Journal of molecular biology 
417, 406–412 (2012). 
44. Lorenz, C. et al. Genomic SELEX for Hfq-binding RNAs identifies genomic 
aptamers predominantly in antisense transcripts. Nucleic acids research 
38, 3794–808 (2010). 
45. Tsui, H. & Feng, G. Transcription of the MutL repair, miaA tRNA 
modification, hfq pleiotropic regulator, and hflA region protease genes of 
Escherichia coli K-12 from clustered Esigma32-specific promoters during. 
Journal of bacteriology (1996).at 
<http://jb.asm.org/content/178/19/5719.short> 
46. Tsui, H. T., Feng, G. & Winkler, M. E. regulators of Escherichia coli K-12. 
gene expression by the Hfq and RpoS global Negative regulation of mutS 
and mutH repair. 179, (1997). 
 
 
114 
47. Vecerek, B., Moll, I. & Bläsi, U. Translational autocontrol of the Escherichia 
coli hfq RNA chaperone gene. RNA (New York, N.Y.) 11, 976–84 (2005). 
48. Carmichael, G., Weber, K. & Niveleau, A. The host factor required for RNA 
phage Qbeta RNA replication in vitro. Intracellular location, quantitation, 
and purification by polyadenylate-cellulose chromatography. Journal of 
Biological 250, 3607–3612 (1975). 
49. Ali Azam, T., Iwata, a, Nishimura, a, Ueda, S. & Ishihama, a Growth phase-
dependent variation in protein composition of the Escherichia coli nucleoid. 
Journal of bacteriology 181, 6361–70 (1999). 
50. Tsui, H.-C. T., Leung, H.-C. E. & Winkler, M. E. Characterization of broadly 
pleiotropic phenotypes caused by an hfq insertion mutation in Escherichia 
coli K-12. Molecular Microbiology 13, 35–49 (1994). 
51. McLellan, C. R. Regulation of the bacterial transposon Tn5. (2012). 
52. Kajitani, M., Kato, a, Wada, a, Inokuchi, Y. & Ishihama, a Regulation of the 
Escherichia coli hfq gene encoding the host factor for phage Q beta. 
Journal of bacteriology 176, 531–4 (1994). 
53. Hussein, R. & Lim, H. N. Disruption of small RNA signaling caused by 
competition for Hfq. Proceedings of the National Academy of Sciences of 
the United States of America 108, 1110–5 (2011). 
54. Moon, K. & Gottesman, S. Competition among Hfq-binding small RNAs in 
Escherichia coli. Molecular Microbiology 82, 1545–1562 (2011). 
55. Sharma, A. K. & Payne, S. M. Induction of expression of hfq by DksA is 
essential for Shigella flexneri virulence. Molecular microbiology 62, 469–79 
(2006). 
56. Hübner, a & Hendrickson, W. A fusion promoter created by a new insertion 
sequence, IS1490, activates transcription of 2,4,5-trichlorophenoxyacetic 
acid catabolic genes in Burkholderia cepacia AC1100. Journal of 
bacteriology 179, 2717–23 (1997). 
57. Simons, R. W. DNA sequence organization of IS10-right of Tn10 and 
comparison with IS10-left. Proc. Natl. Acad. Sci 79, 2608–2612 (1982). 
58. Ma, Charles and Simons, R. W. The IS10 antisense RNA blocks ribosome 
binding at the transposase translation initiation site. The EMBO journal 9, 
1267–1274 (1990). 
 
 
115 
59. Case, C. & Simons, E. The IS10 transposase mRNA is destabilized during 
antisense RNA control. The EMBO journal 9, 1259–1266 (1990). 
60. Buchon, N. & Vaury, C. RNAi: a defensive RNA-silencing against viruses 
and transposable elements. Heredity 96, 195–202 (2006). 
61. Obbard, D. J., Gordon, K. H. J., Buck, A. H. & Jiggins, F. M. The evolution 
of RNAi as a defence against viruses and transposable elements. 
Philosophical transactions of the Royal Society of London. Series B, 
Biological sciences 364, 99–115 (2009). 
62. Rosner, J. L. Formation, induction, and curing of bacteriophage P1 
lysogens. Virology 48, 679–689 (1972). 
63. Foster, T. J., Davis, M. a, Roberts, D. E., Takeshita, K. & Kleckner, N. 
Genetic organization of transposon Tn10. Cell 23, 201–13 (1981). 
64. Bolivar, F. & Backman, K. Complementation analysis of the restriction and 
modification of DNA in Escherichia coli. Journal of molecular biology 68, 
245–267 (1979). 
65. Bender, J. & Kuo, J. Genetic evidence against intramolecular rejoining of 
the donor DNA molecule following IS10 transposition. Genetics (1991).at 
<http://www.genetics.org/cgi/content/abstract/128/4/687> 
66. Ely, B. Vectors for transposon mutagenesis of non-enteric bacteria. 
Molecular & general genetics : MGG 200, 302–4 (1985). 
67. Guillier, M. & Gottesman, S. Remodelling of the Escherichia coli outer 
membrane by two small regulatory RNAs. Molecular microbiology 59, 231–
47 (2006). 
68. Coros, A. & Twiss, E. Genetic evidence that GTP is required for 
transposition of IS903 and Tn552 in Escherichia coli. Journal of … 187, 
4598–4606 (2005). 
69. Huang, H.-Y. et al. sRNAMap: genomic maps for small non-coding RNAs, 
their regulators and their targets in microbial genomes. Nucleic acids 
research 37, D150–4 (2009). 
70. Gibb, E. a & Edgell, D. R. Multiple controls regulate the expression of 
mobE, an HNH homing endonuclease gene embedded within a 
ribonucleotide reductase gene of phage Aeh1. Journal of bacteriology 189, 
4648–61 (2007). 
 
 
116 
71. Celesnik, H., Deana, A., And & Belasco, Joel, G. Extraction of bacterial 
RNA by the hot phenol method. RNA Turnover in Bacteria, Archaea and 
Organelles 92 (2008). 
72. Siguier, P., Perochon, J., Lestrade, L., Mahillon, J. & Chandler, M. ISfinder: 
the reference centre for bacterial insertion sequences. Nucleic acids 
research 34, D32–6 (2006). 
73. Schilling, D. & Gerischer, U. The Acinetobacter baylyi Hfq gene encodes a 
large protein with an unusual C terminus. Journal of bacteriology 191, 
5553–62 (2009). 
74. Sonnleitner, E., Moll, I. & Bläsi, U. Functional replacement of the 
Escherichia coli hfq gene by the homologue of Pseudomonas aeruginosa. 
Microbiology (Reading, England) 148, 883–91 (2002). 
75. Chen, S. et al. A bioinformatics based approach to discover small RNA 
genes in the Escherichia coli genome. Bio Systems 65, 157–77 (2002). 
76. Ishikawa, H., Otaka, H., Maki, K., Morita, T. & Aiba, H. The functional Hfq-
binding module of bacterial sRNAs consists of a double or single hairpin 
preceded by a U-rich sequence and followed by a 3’ poly(U) tail. RNA (New 
York, N.Y.) 18, 1062–74 (2012). 
77. Miller, R. & Bharat, K. SPHINX: a framework for creating personal, site-
specific Web crawlers. Computer Networks and ISDN Systems 30, 119–
130 (1998). 
78. Brown, L. & Elliott, T. Efficient translation of the RpoS sigma factor in 
Salmonella typhimurium requires host factor I, an RNA-binding protein 
encoded by the hfq gene. Journal of bacteriology 178, 3763–3770 (1996). 
79. Hajnsdorf, E. & Régnier, P. Host factor Hfq of Escherichia coli stimulates 
elongation of poly(A) tails by poly(A) polymerase I. Proceedings of the 
National Academy of Sciences of the United States of America 97, 1501–5 
(2000). 
80. Lisitsky, I. & Schuster, G. Preferential degradation of polyadenylated and 
polyuridinylated RNAs by the bacterial exoribonuclease polynucleotide 
phosphorylase. European Journal of Biochemistry 261, 468–74 (1999). 
81. Morita, T., Maki, K. & Aiba, H. RNase E-based ribonucleoprotein 
complexes: mechanical basis of mRNA destabilization mediated by 
bacterial noncoding RNAs. Genes & development 19, 2176 (2005). 
 
 
117 
82. Naville, M., Ghuillot-Gaudeffroy, A., Marchais, A. & Gautheret, D. ARNold: 
A web tool for the prediction of Rho-independent transcription terminators. 
RNA Biology 8, 11–13 (2011). 
83. Brescia, C. C. Identification of the Hfq-binding site on DsrA RNA: Hfq binds 
without altering DsrA secondary structure. Rna 9, 33–43 (2003). 
84. Zuker, M. Mfold web server for nucleic acid folding and hybridization 
prediction. Nucleic Acids Research 31, 3406–3415 (2003). 
85. Smith, C., Heyne, S., Richter, A. S., Will, S. & Backofen, R. Freiburg RNA 
Tools: a web server integrating INTARNA, EXPARNA and LOCARNA. 
Nucleic acids research 38, W373–7 (2010). 
86. Azam, T. A., Iwata, A., Nishimura, A., Azam, T. A. L. I. & Ueda, S. Growth 
Phase-Dependent Variation in Protein Composition of the Escherichia coli 
Nucleoid Growth Phase-Dependent Variation in Protein Composition of the 
Escherichia coli Nucleoid. Society (1999). 
87. Sousa, S. a, Ramos, C. G., Moreira, L. M. & Leitão, J. H. The hfq gene is 
required for stress resistance and full virulence of Burkholderia cepacia to 
the nematode Caenorhabditis elegans. Microbiology (Reading, England) 
156, 896–908 (2010). 
88. Waters, L. S. & Storz, G. Regulatory RNAs in bacteria. Cell 136, 615–28 
(2009). 
89. Coenye, T. & Vandamme, P. Diversity and significance of Burkholderia 
species occupying diverse ecological niches. Environmental Microbiology 
5, 719–729 (2003). 
90. Savageau, M. Escherichia coli habitats, cell types, and molecular 
mechanisms of gene control. American Naturalist 122, 732–744 (1983). 
91. Hübner, A., Danganan, C., Xun, L., Chakrabarty, A. M. & Hendrickson, W. 
2, 4, 5-trichlorophenoxyacetic acid metabolism in Burkholderia cepacia 
AC1100: characterization of the tftC and tftD genes and locations of the tft 
operons on multiple. Applied and … 64, 2086–93 (1998). 
92. Hankins, J. S., Denroche, H. & Mackie, G. a Interactions of the RNA-
binding protein Hfq with cspA mRNA, encoding the major cold shock 
protein. Journal of bacteriology 192, 2482–90 (2010). 
93. Narberhaus, F., Waldminghaus, T. & Chowdhury, S. RNA thermometers. 
FEMS microbiology reviews 30, 3–16 (2006). 
 
 
118 
94. Eichenbaum, Z. & Livneh, Z. UV light induces IS10 transposition in 
Escherichia coli. Genetics 149, 1173–81 (1998). 
95. Stoebel, D. M., Hokamp, K., Last, M. S. & Dorman, C. J. Compensatory 
evolution of gene regulation in response to stress by Escherichia coli 
lacking RpoS. PLoS genetics 5, e1000671 (2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
119 
Curriculum Vitae – Brian Munshaw 
 
Education 
M.Sc 2010 – 2012 – University of Western Ontario – Biochemistry  
B.Ed: 2008-2009 University of Western Ontario – Intermediate/Senior Chemistry 
and Biology 
B.MSc: 2003-2008 University of Western Ontario – Honours Microbiology and 
Immunology 
 
Awards 
Ontario Graduate Scholarship 
Western Graduate Scholarship 
